WO2022121864A1 - Marker combination for skin typing and use thereof - Google Patents

Marker combination for skin typing and use thereof Download PDF

Info

Publication number
WO2022121864A1
WO2022121864A1 PCT/CN2021/135870 CN2021135870W WO2022121864A1 WO 2022121864 A1 WO2022121864 A1 WO 2022121864A1 CN 2021135870 W CN2021135870 W CN 2021135870W WO 2022121864 A1 WO2022121864 A1 WO 2022121864A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
moraxella
oslo
acnes
level
Prior art date
Application number
PCT/CN2021/135870
Other languages
French (fr)
Chinese (zh)
Inventor
王久存
夏晶晶
克鲁德曼·吉恩
刘晓
钟倩
李志明
Original Assignee
复旦大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 复旦大学 filed Critical 复旦大学
Priority to KR1020237023407A priority Critical patent/KR20230118928A/en
Priority to JP2023535014A priority patent/JP2023552837A/en
Publication of WO2022121864A1 publication Critical patent/WO2022121864A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/44Staphylococcus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
    • G01N2333/212Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella or Psychrobacter
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/20Dermatological disorders

Definitions

  • the present invention relates to the field of biomedicine, in particular to a marker combination for skin typing and its application.
  • the purpose of the present invention is to classify the population based on the characteristics of the skin microbiome, thereby helping the industry to develop skin care products and medicines that are more suitable for specific populations for different skin types.
  • the present invention will focus on the two bacteria that dominate skin typing, Moraxella osloensis and Cutibacterium acnes, as well as skin-abundant bacteria that play an important role in host health and disease. on one of the bacterial colonies of the species, Staphylococcus epidermidis.
  • the correlation between the distribution abundance of three target skin symbionts on the face and the host skin phenotype was determined. The bacteria that promote skin aging - M. osloensis.
  • M. osloensis or a detection reagent thereof for (a) skin typing; and/or (b) judging or characterizing skin conditions or using For preparing a reagent or kit for (a) skin typing; and/or (b) determining or characterizing skin condition.
  • the skin condition includes: skin age, skin moisture content, skin elasticity, skin color, and skin aging degree.
  • the aging degree of the skin is judged based on one or more phenotypes selected from the group consisting of porphyrin, oil, water content, gloss, pore area, skin yellowness, pore size, and pigmentation.
  • the reagent or kit further includes a reagent for detecting Propionibacterium acnes (C. acnes).
  • the reagent or kit further includes a reagent for detecting Moraxella bovoculi and/or Psychrobacter sp.
  • the reagent or kit further comprises detection of Propionibacterium avidum, Propionibacterium granulosum, Staphylococcus, Propionibacterium acnes and/or Staphylococcus phage reagent.
  • the reagent or kit further includes a reagent for detecting Staphylococcus epidermidis (S. epidermidis).
  • a second aspect of the present invention provides a marker combination comprising M. osloensis and C. acnes.
  • the marker combination further includes Moraxella bovoculi and/or Psychrobacter sp..
  • the marker combination further includes Propionibacterium avidum, Propionibacterium granulosum, Staphylococcus, Propionibacterium acnes and/or Staphylococcus phage.
  • the marker combination further includes Staphylococcus epidermidis (S. epidermidis).
  • the marker combination is used for (a) skin typing; and/or (b) judging skin state.
  • the skin condition includes: skin age, skin moisture content, skin elasticity, skin color, and skin aging degree.
  • the aging degree of the skin is judged based on one or more phenotypes selected from the group consisting of porphyrin, oil, water content, gloss, pore area, skin yellowness, pore size, and pigmentation.
  • the marker or marker combination is derived from a skin sample, preferably from whole body skin or facial skin, more preferably from cheek, forehead, and nose.
  • the marker or marker combination is derived from skin samples of Asian population.
  • the marker or marker combination is derived from cheek, forehead, and alar samples.
  • the level of each marker in the marker combination is detected by one or more methods of the following group: sequencing, PCR, protein quantitative detection.
  • the method for detecting the level of the marker group further includes one or more methods selected from the group consisting of: quantitative PCR for characteristic genes, qPCR, real-time quantitative PCR, metagenomics analysis, 16s RNA sequencing , mass spectrometry, and western blotting.
  • the ratio (M/ C) When the following conditions are met: M/C ⁇ 1.3, preferably, M/C ⁇ 0.8, more preferably M/C ⁇ 0.4, then the skin type is type C (or type I), and its phenotype includes: oil High content, high water content, good skin elasticity, low skin aging, bright skin color.
  • the ratio (M/ C) When the following conditions are met: 0.3 ⁇ M/C ⁇ 2.5, preferably, 0.3 ⁇ M/C ⁇ 2.3, more preferably, 0.8 ⁇ M/C ⁇ 1.8, then the skin type is mixed (or type II) , and its phenotypes include: medium oil content, medium water content, average skin elasticity, moderate skin aging, and medium skin color.
  • the ratio (M/ C) When the following conditions are met: M/C ⁇ 0.5, preferably, M/C ⁇ 1.8, more preferably, M/C ⁇ 2.2, then the skin type is M type (type III), and its phenotype includes skin oil Low content, low water content, poor skin elasticity, high degree of skin aging, dull skin color.
  • the ratio (M/ C) When the following conditions are met: M/C ⁇ 1.5, preferably, M/C ⁇ 1.25, the skin type is type C (or type I), and its phenotype includes high oil content, high water content, and good skin elasticity , Low degree of skin aging, bright skin color.
  • the ratio (M/ C) When the following conditions are met: M/C ⁇ 0.5, preferably, M/C ⁇ 0.35, the skin type is type C (or type I), and its phenotype includes high oil content, high water content, good skin elasticity, Low level of skin aging, bright skin color.
  • the ratio (M/C) of the level (such as content) (M) of the Moraxella oslo to the level (such as content) (C) of the P. acnes is derived from a sample from the nose wing ) when the following conditions are met: 0.35 ⁇ M/C ⁇ 0.7, preferably, 0.35 ⁇ M/C ⁇ 0.6, more preferably, 0.35 ⁇ M/C ⁇ 0.55, the skin type is mixed type (or type II), which Phenotypes include: moderate oil content, moderate moisture content, moderate skin elasticity, moderate skin aging, and moderate skin color.
  • the ratio (M/C) of the level (such as content) (M) of the Moraxella oslo to the level (such as content) (C) of the P. acnes is derived from a sample from the nose wing ) when the following conditions are met: M/C ⁇ 0.5, preferably, M/C ⁇ 0.55, the skin type is M type (type III), and its phenotype includes low skin oil content, low water content, poor skin elasticity, High degree of skin aging, dull skin color.
  • a third aspect of the present invention provides a method for skin typing or judging skin state, the method comprising:
  • the subject to be tested is from an Asian population.
  • step (2) according to the relative value (such as M/C) of the level (such as content) (M) of Moraxella oslo and the level (such as content) (C) of P. acnes Type the skin, or determine the skin condition of a sample.
  • the skin condition includes skin age, skin moisture content, skin elasticity, skin color, and skin aging degree.
  • the level (eg content) (M) of Moraxella oslo and the level (eg content) of P. acnes in the sample of the subject to be tested by one or more methods selected from the following group (C) Confirmation: sequencing, PCR, protein quantitative detection.
  • the method for detecting the level (eg content) (M) of Moraxella oslo and the level (eg content) (C) of Propionibacterium acnes in the sample further comprises a method selected from the group consisting of: One or more methods: quantitative PCR for signature genes, qPCR, real-time quantitative PCR, metagenomics analysis, 16s RNA sequencing, mass spectrometry, Western blotting.
  • the ratio (M/C) of the Moraxella oslo (M) to the level (such as content) (C) of the P. acnes in the sample meets the following conditions: M/C ⁇ 1.3, preferably, M/C ⁇ 0.8, more preferably M/C ⁇ 0.4, then the skin type is C type (or type I), and its phenotype includes: high oil content, high water content, Good skin elasticity, low skin aging, bright skin color.
  • the ratio (M/C) of the level (eg content) (M) of the Moraxella oslo in the sample to the level (eg content) (C) of the P. acnes When the following conditions are met: 0.3 ⁇ M/C ⁇ 2.5, preferably, 0.3 ⁇ M/C ⁇ 2.3, more preferably, 0.8 ⁇ M/C ⁇ 1.8, then the skin type is mixed (or type II), and its Phenotypes include: moderate oil content, moderate moisture content, moderate skin elasticity, moderate skin aging, and moderate skin color.
  • the ratio (M/C) of the level (eg content) (M) of the Moraxella oslo in the sample to the level (eg content) (C) of the P. acnes When the following conditions are met: M/C ⁇ 0.5, preferably, M/C ⁇ 1.8, more preferably, M/C ⁇ 2.2, the skin type is M type (type III), and its phenotype includes low skin oil content , low water content, poor skin elasticity, high degree of skin aging, dull skin color.
  • the sample is derived from the cheek, and the ratio of the level (such as content) (M) of Moraxella oslo in the sample to the level (such as content) (C) of Propionibacterium acnes ( When M/C) meets the following conditions: M/C ⁇ 0.8, preferably, M/C ⁇ 0.75, then the skin type is C type (or type I), and its phenotype includes high oil content, high water content, skin Good elasticity, low skin aging, bright skin color.
  • the sample is derived from the cheek, and the ratio of the level (such as content) (M) of Moraxella oslo in the sample to the level (such as content) (C) of Propionibacterium acnes ( When M/C) meets the following conditions: 0.75 ⁇ M/C ⁇ 2, preferably, 0.8 ⁇ M/C ⁇ 1.7, then the skin type is mixed type (or type II), and its phenotype includes: medium oil content, Moderate moisture content, average skin elasticity, moderate skin aging, and moderate skin tone.
  • the sample is derived from the cheek, and the ratio of the level (such as content) (M) of Moraxella oslo in the sample to the level (such as content) (C) of Propionibacterium acnes ( When M/C) meets the following conditions: M/C ⁇ 1.7, the skin type is M type (type III), and its phenotypes include low skin oil content, low water content, poor skin elasticity, high skin aging, and skin Dull in color.
  • M level of Moraxella oslo in the sample
  • C content of Propionibacterium acnes
  • the ratio of the level (eg content) (M) of Moraxella oslo in the sample to the level (eg content) (C) of Propionibacterium acnes (M/C)
  • M/C the ratio of the level (eg content) (M) of Moraxella oslo in the sample to the level (eg content) (C) of Propionibacterium acnes
  • the sample is derived from the forehead, the ratio of the level (eg content) (M) of Moraxella oslo in the sample to the level (eg content) (C) of Propionibacterium acnes ( M/C) when the following conditions are met: 1.25 ⁇ M/C ⁇ 2.5, preferably, 1.3 ⁇ M/C ⁇ 2.2, the skin type is mixed (or type II), and its phenotype includes: medium oil content, high The amount of water is medium, the skin elasticity is average, the skin aging is medium, and the skin color is medium.
  • the sample is derived from the forehead, the ratio of the level (eg content) (M) of Moraxella oslo in the sample to the level (eg content) (C) of Propionibacterium acnes ( When M/C) meets the following conditions: M/C ⁇ 2, preferably ⁇ 2.2, the skin type is M type (type III), and its phenotype includes low skin oil content, low water content, and poor skin elasticity , High degree of skin aging, dull skin color.
  • the ratio of the level (eg content) (M) of Moraxella oslo in the sample to the level (eg content) (C) of Propionibacterium acnes (M/C)
  • M/C the ratio of the level (eg content) (M) of Moraxella oslo in the sample to the level (eg content) (C) of Propionibacterium acnes
  • M/C is derived from a sample from the nose wing, and the ratio of the level (such as content) (M) of Moraxella oslo in the sample to the level (such as content) (C) of Propionibacterium acnes (
  • M/C meets the following conditions: 0.35 ⁇ M/C ⁇ 0.7, preferably, 0.35 ⁇ M/C ⁇ 0.6, more preferably, 0.35 ⁇ M/C ⁇ 0.55, the skin type is mixed (or type II) ), and their phenotypes include: medium oil content, medium water content, average skin elasticity, moderate skin aging, and medium skin color.
  • it is derived from a sample from the nose wing, and the ratio of the level (such as content) (M) of Moraxella oslo in the sample to the level (such as content) (C) of Propionibacterium acnes ( M/C) when the following conditions are met: M/C ⁇ 0.5, preferably, M/C ⁇ 0.55, the skin type is M type (type III), and its phenotype includes low skin oil content, low water content, skin Poor elasticity, high degree of skin aging, dull skin color.
  • the relative value meets the following conditions: when M/C ⁇ 1.3, the skin is type C, and when M/C ⁇ 0.5, the skin is type M.
  • the relative value meets the following condition: when 0.3 ⁇ M/C ⁇ 2.5, the skin is of mixed type.
  • the level (such as content) (M) of the Moraxella oslo increases, it indicates that the skin condition is increased skin age, dark and yellow complexion, reduced skin moisture content, sebum and porphyrin content reduce.
  • the fourth aspect of the present invention provides a reagent combination for skin typing and/or skin condition detection, the reagent combination comprising reagents for detecting each marker in the combination described in the second aspect of the present invention.
  • the reagent is used to detect the level (eg content) of each marker.
  • the reagent includes a substance for detecting the level of each marker in the combination described in the second aspect of the present invention by one or more methods selected from the group consisting of sequencing, PCR, and quantitative protein detection.
  • the method for detecting the marker level further includes: quantitative PCR of characteristic genes, qPCR, real-time quantitative PCR, metagenomic analysis, 16s RNA sequencing, mass spectrometry analysis, and western blotting.
  • the reagent combination includes:
  • a first detection reagent for detecting the level (M) of Moraxella oslo for detecting the level (M) of Moraxella oslo;
  • a fifth aspect of the present invention provides a kit comprising the reagent combination described in the second aspect of the present invention.
  • each marker in the combination described in the second aspect of the present invention is used as a standard.
  • a sixth aspect of the present invention provides a system for classifying the skin of an object to be tested and/or judging the skin state of the object to be tested, the system comprising:
  • a feature receiving module is used for receiving skin sample feature data;
  • the feature data includes: the quantitative information of each of Moraxella oslo (M) and P. acnes (C) in the skin sample ;
  • a calculation processing module for calculating the feature data from the feature receiving module, so as to obtain the respective proportions of the respective features or the proportional relationship between the respective features; and based on the obtained respective proportions or the relationship between the respective features A proportional relationship, compared with a standard value for skin type or characterization, resulting in a judgment of skin type and/or skin condition;
  • the subject is a human.
  • the subject is an Asian population.
  • the objects include men and women.
  • the subject includes infants, adolescents or adults.
  • the quantitative information includes the respective levels (eg content) of Moraxella oslo (M) and Propionibacterium acnes (C).
  • the proportional relationship includes the relative values of the respective levels (eg contents) of Moraxella oslo (M) and Propionibacterium acnes (C) in the skin sample, such as M/C.
  • M Moraxella oslo
  • C Propionibacterium acnes
  • the system can be divided into at least two types according to the skin condition.
  • the method for obtaining the quantitative information includes: sequencing, PCR, and quantitative protein detection.
  • the method for obtaining the quantitative information further includes: quantitative PCR for characteristic genes, qPCR, real-time quantitative PCR, metagenomics analysis, 16s RNA sequencing, mass spectrometry analysis, and western blotting.
  • the feature receiving module includes a sample collector and a feature signal input end.
  • the calculation processing module includes a processor and a storage, wherein the storage stores threshold information of skin type and/or skin state.
  • the output module includes any terminal, preferably a display, a printer, a tablet computer (PAD), and a smart phone.
  • the modules are connected in a wired or wireless manner.
  • a seventh aspect of the present invention provides a method for screening substances or ingredients for improving skin condition, comprising:
  • the screening bacteria is Moraxella oslo (M), P. acnes (C), or screening bacteria (mixed bacteria) comprising Moraxella oslo and/or P. acnes;
  • the content of Moraxella oslo or the relative level (such as relative content) (M/C) between Moraxella oslo and P. acnes increases, it indicates the substance to be screened Or the ingredients are substances used to treat acne.
  • the level (such as content) of Moraxella oslo decreases or the relative level (such as relative content) (M/C) between Moraxella oslo and P. acnes decreases, it indicates that the The substances or ingredients to be screened are skin anti-aging substances.
  • the level (such as content) of P. acnes increases or the relative level (such as relative content) (C/M) between P. acnes and Moraxella oslo increases, it indicates that the The substances or ingredients to be screened are skin anti-aging substances.
  • the level (such as content) of P. acnes decreases or the relative level (such as relative content) (C/M) between P. acnes and Moraxella oslo decreases, it indicates that the The substance or ingredient to be screened is a substance for treating acne.
  • the eighth aspect of the present invention provides a use of the marker combination according to the second aspect of the present invention or the reagent combination according to the fourth aspect of the present invention, for preparing a kit for use in (a) skin typing; and/or (b) judging or characterizing skin condition.
  • the ninth aspect of the present invention provides the use of the combination of markers described in the second aspect of the present invention or the combination of reagents described in the fourth aspect of the present invention for screening substances or components that improve skin condition.
  • Figure 1 shows a schematic diagram of the sampled skin site.
  • Figure 2 shows the microbial composition of the facial skin of the Han population.
  • Figure 3 shows the analysis of the optimal number of clusters for different parts.
  • Figure 4A and B show the clustering results of the forehead, where the box plots represent the average distance between samples in the two groups, respectively, and the red line represents the average distance between samples in different groups.
  • 4A is the JS divergence (Jensen-Shannon divergence)
  • 4B is the Bray-Curtis dissimilarity (Bray-Curtis dissimilarity).
  • Figure 4C,D show the relative levels of P. acnes or M. oslo on the forehead, with each dot representing a sample.
  • Figure 4E and F show the clustering results of cheeks, where the box plots represent the average distance between samples in the two groups, respectively, and the red line represents the average distance between samples in different groups.
  • 4E is JS divergence (Jensen-Shannon divergence)
  • 4F is Bray-Curtis dissimilarity (Bray-Curtis dissimilarity).
  • Figures 4G,H show relative levels of P. acnes or M. oslo in cheeks, with each dot representing a sample.
  • Figure 4I and J show the clustering results of the nose ala, where the box plots represent the average distance between samples in the two groups, respectively, and the red line represents the average distance between samples in different groups.
  • 4I is the JS divergence (Jensen-Shannon divergence)
  • 4J is the Bray-Curtis dissimilarity (Bray-Curtis dissimilarity).
  • Figure 4K,L show the relative levels of P. acnes or M. oslo in the nasal ala, with each dot representing a sample.
  • Figure 5 shows the differential microorganisms between different skin types, with colors representing the relative levels of microorganisms, one sample per column and one microorganism per row.
  • Figure 6 shows the microbial network characteristics of different skin types, with M-cutotype-enriched microbial species on the left and C-cutotype-enriched microbial species on the right. Each dot represents a species, and each color of the bouquet represents a species. It can be seen from the figure that the enriched microorganisms in one skin type are positively correlated with each other and negatively correlated with the enriched species of another skin type. Different skin types show different microbial network compositions.
  • Figure 7 shows the differences in functional enrichment of skin microbial genes for different skin types.
  • Figure 8 shows phenotypic differences between different skin types.
  • Figure 9 shows the correlation analysis between Moraxella oslo and age and skin phenotype: adjusted P value is less than 0.05.
  • Figure 10 shows that aceA/aceB genes are enriched in M-Cutotype.
  • Figure 11 shows that the beta-Carotene synthesis pathway is enriched for M-Cutotype.
  • Figure 12 shows the functional enrichment analysis of RNAseq differentially expressed genes in human keratinocyte HaCaT treated with Moraxella oslo supernatant and blank control group.
  • Figure 13 shows the utilization of various water-soluble carbon source compounds by Moraxella oslo.
  • the left picture is measured by CCK-8 kit, and the right picture is measured by Dye mix A.
  • Figure 14 shows the results of skin type validation using Singapore Chinese skin metagenomic data.
  • Figure 15 shows the results of skin type validation using Philippine and Italian skin metagenomic data.
  • Figure 16 shows a heatmap of the correlation between species level and host phenotype of three dermatosymbionts.
  • Figure 17 shows a graph of Moraxella oslo-HaCaT-QPCR results.
  • Figure 18 shows a graph of P. acnes-HaCaT-QPCR results.
  • Figure 19 shows a graph of S. epidermidis-HaCaT-QPCR results.
  • Moraxella oslo can be used to characterize skin conditions or for skin typing for the first time, and the present invention also discovered a new marker combination for the first time: Moraxella oslo and C. acnes Acidobacter.
  • the marker combination of the present invention can (a) classify the skin; and/or (b) judge the skin state, has the advantages of high sensitivity and high specificity, and has important application value. On this basis, the inventors have completed the present invention.
  • the term "marker combination” refers to a combination of two or more markers.
  • the level of the marker substance is determined by the ratio of the presence and/or expression of the two microorganisms.
  • the term "individual” refers to animals, especially mammals, such as primates, preferably humans.
  • the term “about” means that the value may vary by no more than 1% from the recited value.
  • the expression “about 100” includes all values between 99 and 101 and (eg, 99.1, 99.2, 99.3, 99.4, etc.).
  • the terms "containing” or “including (including)” can be open, semi-closed, and closed. In other words, the term also includes “consisting essentially of,” or “consisting of.”
  • M bacteria Moraxella Osloensis, M.osloensis, hereinafter referred to as M bacteria
  • Moraxella oslo Moraxella spp., bacilli, gram-negative, chemoorganotrophic bacteria. Can not use carbohydrates to produce acid.
  • C bacteria Propionibacterium acnes, Cutibacterium acnes, C. acnes, hereinafter referred to as C bacteria
  • Propionibacterium acnes a gram-positive bacillus, is a genus of Propionibacterium in the Actinomycete Actinomycete Actinomycetales. Important colonizer of human skin, involved in maintaining skin health, and can also act as a causative agent of acne vulgaris.
  • Staphylococcus epidermidis Staphylococcus epidermidis, Staphylococcus epidermidis, S. epidermidis
  • Staphylococcus epidermidis It is a gram-positive coccus that breeds on the epidermis of organisms. It exists in the skin, vagina and other parts of the human body. Because it often accumulates into grape clusters, it is named Staphylococcus epidermidis.
  • the skin can be further classified into M-Cutotype type (referred to as M type), mixed type, and C-Cutotype type (referred to as C type).
  • M type M-Cutotype
  • C type C-Cutotype type
  • C-Cutotype As used herein, the terms "C-Cutotype”, “C-type” are used interchangeably and refer to a type of microbe-based skin typing characterized by high levels of aggregation of P. acnes (C. acnes).
  • M-Cutotype As used herein, the terms "M-Cutotype", “M-type” are used interchangeably and refer to a type of microbe-based skin typing characterized by high levels of aggregation of M. osloensis.
  • skin elasticity depends on, but is not limited to, the adequacy of skin moisture, collagen, elastin, and natural fats, among others.
  • skin color depends on, but is not limited to, skin radiance, skin tone, yellowness, and the like.
  • skin aging depends on, but is not limited to, increased skin porphyrins, decreased skin moisture content and radiance, enlarged and enlarged pores, skin oil imbalance, and dull skin.
  • M/C ratio can be obtained in the following ways: 1. 16sRNA sequencing; 2. Metagenome sequencing; 3. Characteristics of two species Sequence design primers, and then use qPCR to obtain the M/C ratio; 4. Detect the specific expressed proteins or metabolites of the two bacteria for quantitative purposes, such as mass spectrometry analysis, Western blotting, etc.
  • the kit of the present invention includes the combination described in the second aspect of the present invention and/or the reagent combination described in the fourth aspect of the present invention.
  • each marker in the combination described in the first aspect of the present invention is used as a standard.
  • the present invention uses Moraxella oslo and Propionibacterium acnes as markers in combination for (a) skin typing; and/or (b) judging skin condition, such as moisture content, skin elasticity, and/or aging degree , has the advantages of high sensitivity and high specificity, and has important application value.
  • the present invention discovers for the first time a new classification method that is different from the previous classification based on the host physiological drive (oily skin, dry skin, wet skin).
  • the new classification method uses skin microorganisms as the classification basis.
  • the microbiome communities of different skin types may react against the host skin by exerting specific functions, which may have certain effects on skin health and skin appearance. Therefore, further research on skin type may contribute to the development of personalized medicine to better maintain skin health.
  • the present invention finds for the first time the correlation between M bacteria and skin phenotype, which is positively correlated with age, and is related to some skin aging phenotypes, such as with the increase of the level of M bacteria, the skin oil decreases, the moisture content decreases, and the luster decreases. It is associated with some typical features of acne, such as increased M bacteria, decreased oil, decreased porphyrins (mostly metabolites of C bacteria, which can be pro-inflammatory), and decreased pore area .
  • the present invention finds for the first time that by increasing the relative level (eg content) of P. acnes, M-type skin can be adjusted to C-type skin, which can be used for skin anti-aging.
  • the present invention finds for the first time that by increasing the relative level (such as content) of Moraxella oslo, the C-type skin can be adjusted to the M-type skin, which is used for the treatment of acne.
  • the present invention finds for the first time that the correlation analysis between single bacteria and skin phenotypes is carried out to explore whether skin microorganisms may cause changes in the skin phenotype of the host, and to provide new insights and new perspectives for the study of the interaction between microorganisms and the host.
  • the present invention finds for the first time that the bacterial supernatant is used to treat the host epidermal cells to explore the interaction relationship between the bacteria and the host at the molecular level, and is not limited to correlation research.
  • the Shanghai resident population was recruited as volunteers for this study. All volunteers participating in this study will be examined by a dermatologist at Shanghai Dermatology Hospital to rule out skin lesions such as dermatitis, eczema, acne, psoriasis, infection, etc. Skin disease, while excluding volunteers treated with systemic or topical antibiotics within the past 6 months. Finally, 294 healthy subjects aged 20-65 were included, including 46 males (M) and 248 females (F) (Table 1).
  • the sampling site was maintained at an indoor temperature of 20 degrees Celsius and a humidity of 50%.
  • the experimenter used a special sterile swab dipped in 0.15M NaCl and 0.1% Tween20 solution to repeatedly wipe the subject's forehead (Fh), cheeks (Ch) and paranasal (Ns) three parts about 4cm2 area, back and forth 20 times . Then, the swab was broken, placed in a 1.5ml sterile EP tube, and frozen at -80°C until the skin microorganism genomic DNA was extracted.
  • the schematic diagram of the sampling part is shown in Figure 1.
  • the samples were amplified by the whole genome amplification method, followed by metagenomic sequencing, and finally the sequencing data of 822 facial skin microbial samples were obtained.
  • the relative abundance of each gene was calculated by SOAP2 (version 2.21), and then the sum of the relative abundances of genes from the same strain was calculated according to the alignment result of each gene, which represented the relative abundance of the strain.
  • the species level and sebum content, stratum corneum water content, transepidermal water loss rate, skin pH value, pigmentation, Porphyrin, skin color, pores and other phenotypes were subjected to correlation analysis (Spearman Rank method) to evaluate the correlation between strain levels and phenotypes; FDR test was performed on the P value of the correlation analysis results, and the corrected P value ⁇ 0.05 indicated The difference is statistically significant.
  • Correlation heatmaps were drawn using the R package pheatmap (version 1.0.12) as the results. Blue, negative correlation; red: positive correlation; significant level of Spearman correlation: *, p ⁇ 0.05; **, p ⁇ 0.01; ***, p ⁇ 0.001.
  • MMP Matrix metalloproteinase
  • the confirmed bacteria are cultured in liquid, and the pure medium without bacteria inoculation is set as the control group;
  • HaCaT cells Culture human keratinocytes 1 ⁇ 10 6 .
  • the bacterial liquid supernatant treatment group (experimental group) and the pure medium control group were set, and each group was repeated three times. Gently shake the culture plate to distribute the cells evenly, and place it into a 37°C, 5% CO 2 cell incubator for culture.
  • Table 3 is three kinds of bacteria used in the present invention.
  • RNA concentration of each sample is adjusted to 200ng/ ⁇ L.
  • ii Take a total of 1 ⁇ g of total RNA for reverse transcription reaction, and store the remaining RNA at -80°C;
  • QuantiFast SYBR Green PCR Kit of QIAGEN company was used for real-time quantitative PCR (Real-time PCR) to detect the relative expression level of the gene.
  • Example 1 Composition of the facial skin microbiome of the Han population
  • Example 2 Population typing analysis based on skin microbiome
  • the skin microbiome like the gut microbiome, is affected by a variety of factors, and there are significant individual differences.
  • the present invention draws on the method of enterotype to classify the population based on skin microbes and explore the driving factors of the type, so as to find the potential rules behind the skin microbiome, and provide a new classification standard for clinical diagnosis.
  • the present invention screened subjects with no missing skin microbiome data in three sites, a total of 247 subjects.
  • Skin type identification was performed on these 247 subjects based on skin microbiome data.
  • the samples from the three parts were clustered using the PAM method, and the CH index was used to determine the optimal number of clusters. Please refer to Figure 3, the results of the CH index show that when the number of clusters is 2, the CH index has the highest score, so the optimal number of clusters in the three parts is 2.
  • the present invention performs genotyping analysis on the samples, which are divided into two categories, and respectively use the JSD distance and the Bray-Curtis distance to perform PCoA analysis on the genotyping results of the samples in the three parts.
  • Figures 4A-L The results show that the sample typing results of the three parts can be effectively divided into two categories, and the microorganisms that contribute the most to the classification are Propionibacterium acnes and Moraxella oslo, namely a The class enriches P. acnes and the other class enriches Moraxella oslo.
  • the two cutotypes we named the two cutotypes as C-Cutotype and M-Cutotype, respectively.
  • the present invention analyzes the differential flora of C-Cutotype and M-Cutotype based on the skin microbiome data of the forehead.
  • the colors represent relative levels (eg, relative abundance) of microorganisms, with one sample per column and one microorganism per row.
  • the results of the differential analysis showed that some microbes prefer a certain skin type, possibly due to the interaction between the flora. For example, P. greedy, P. granulosum, staphylococcus, P. acnes and staphylococcus phage were enriched in C-Cutotype.
  • Moraxella bovoculi and Psychrobacter sp. were enriched.
  • correlation analysis is performed based on the relative levels of the differential flora, and is displayed in the form of a network diagram.
  • the results show that there is a strong positive correlation between microorganisms enriched in the same skin type, while a strong negative correlation exists between microorganisms enriched between different skin types.
  • the results of this analysis indicate that microorganisms enriched in the same skin type may occupy different ecological niches, form a stable ecological network with each other, and build a strong microbial community to resist other microorganisms including opportunistic and New colonization of potentially pathogenic microorganisms.
  • Type C Hybrid M type cheek ⁇ 0.75 0.75 ⁇ M/C ⁇ 1.68 ⁇ 1.68 forehead ⁇ 1.24 1.24 ⁇ M/C ⁇ 2.18 ⁇ 2.18 Nose ⁇ 0.34 0.34 ⁇ M/C ⁇ 0.55 ⁇ 0.55
  • the skin classification sampling principle in clinical application the facial skin parts that need to be improved, and then refer to the above data classification.
  • C bacteria the full name of C bacteria is Propionibacterium acnes, and its level (eg abundance) is closely related to skin acne.
  • M bacteria There are very few related reports on M bacteria. The present study finds for the first time that M bacteria are correlated with skin phenotypes, are positively correlated with age, and are associated with some skin aging phenotypes.
  • the inventors conducted experiments on changes in skin texture and M/C of subjects, and obtained the results in Table 2, which showed that the M/C ratio was related to skin texture.
  • As the level of M bacteria increased skin oil decreased, moisture content decreased, gloss decreased, and yellow value (skin dullness) increased; associated with some typical features of acne, such as increased M bacteria, decreased oil, porphyrin Morphine (mostly C bacteria metabolites, which can promote inflammation) decreased, and the pore area decreased.
  • Table 7 lists the correlation between related phenotypes and M/C value, and all phenotypes are significantly correlated (p ⁇ 0.05).
  • this system is known to be responsible for carbohydrate transport and phosphorylation and is associated with the ability to metabolize glucose, maltose, lactose, fructose and cellobiose, possibly reflecting C-Cutotype's dependence on carbohydrates as a nutrient source.
  • Moraxella oslo found that the microbe was unable to utilize any carbohydrates and relied on fatty acids and alcohols as carbon sources. This further suggests that the two skin types may constitute two communities with different nutritional requirements.
  • the skin microenvironment is the growth environment of skin microorganisms, it determines the nutrients available to the microorganisms. Therefore, to explore whether the skin phenotype is the driving factor for the different skin types, we further analyzed the phenotypic differences between the two skin types. Referring to Figure 7, it was found that the two skin types had significant differences in stratum corneum moisture, oil, and skin color. In contrast, C-Cutotype has higher oil and moisture content, while M-Cutotype has drier skin. Since oil is the main source of nutrients for microbes, this result further suggests that differences in our nutritional requirements are the driving factors for different skin types.
  • the skin phenotypic characteristics of M-Cutotype were similar to those of the elderly, therefore, we compared whether there were differences in age between the two skin types. Please refer to Figure 8.
  • the age of the M-Cutotype group was significantly larger than that of the C-Cutotype group, but further analysis found that both C-Cutotype and M-Cutotype existed in different age groups, that is, C-Cutotype in the elderly , M-Cutotype is present in young adults. Therefore, we guess that age is not the real determinant, and nutritional needs are the direct determinant.
  • the difference in age may be due to changes in host physiology during aging that affect the skin phenotype, resulting in an older M-Cutotype.
  • Example 5 Potential targets for skin aging by M bacteria
  • alkylphenol ethoxylates have estrogen-like activities, and it has been proved that these compounds can mimic the effect of estradiol in vivo and in vitro, and are called environmental estrogens. Therefore, skin microbes have the potential to interfere with the production of estradiol, which is essential for preventing skin aging (see Figure 10).
  • RNA-Seq Signal pathway enrichment analysis of differentially expressed genes by RNA-Seq suggested that Moraxella oslo could affect skin cells through signaling pathways, mainly including regulation of collagen synthesis and decomposition. Please refer to Figure 12.
  • Moraxella oslo was known to be associated with age and skin aging phenotypes.
  • a single skin surface compound was used to incubate Moraxella oslo, and the number of viable bacteria was examined to reflect the microbial utilization of different skin surface compounds and the toxicity of specific compounds to Moraxella oslo.
  • the growth of Moraxella oslo can be regulated, so as to achieve the purpose of delaying aging.
  • CCK-8 and Dye mix A were used to explore the effects of 32 skin surface compounds on the growth of Moraxella oslo.
  • the compounds are: L-lysine, L-glutamine, L-histidine, L-arginine, taurocholic acid, creatinine, D-glucose, L-lactic acid, glycerol, 2-carboxybenzaldehyde , urea, SDS, L-threonine, L-tryptophan, glycine, L-methionine, L-serine, L-glutamic acid, L-phenylalanine, L-cystine, L-tyrosine Acid, L-Leucine, L-Isoleucine
  • L-ornithine hydrochloride L-citrulline, L-proline, L-valine, L-alanine, D-aspartic acid, trans-4-hydroxy-L- Proline, uric acid, taurine.
  • L-glutamine, L-histidine, L-serine, and L-proline significantly promoted the growth of Moraxella oslo, while SDS had a significant inhibitory effect.
  • the present invention proves that skin types exist widely and are not affected by skin location, race, health status, and the like.
  • a skin condition typing system the system includes a feature receiving module, a calculation processing module and a result output module, each module is connected by wire or wireless, and the typing steps are as follows:
  • the skin sample characteristic data is the respective levels of Moraxella oslo and P. acnes.
  • the collection site is the same as that described in Embodiment 1, and the detection method is as described in the detection method.
  • the processing module receives the skin sample characteristic data from the characteristic receiving module, calculates the respective ratios of the quantified Moraxella oslo and P. acnes or the relative ratios between each other, and based on the obtained respective ratios or the relative proportions of each other, compared with the standard value of skin type or characteristic characterization, so as to obtain the judgment result of skin type and/or skin condition
  • a result output module can be any terminal, such as a display, a printer, a tablet computer (PAD), a smart phone, etc., for receiving and outputting the judgment result.
  • the system includes a storage, wherein threshold information of standard values is stored in the storage.
  • the standard values corresponding to the skin type and/or skin state are:
  • Skin type is C (or type I): when the ratio (M/C) of the level (eg content) (M) of the Moraxella oslo to the level (eg content) (C) of the P. acnes When the following conditions are met: M/C ⁇ 1.3, preferably, M/C ⁇ 0.8, more preferably M/C ⁇ 0.4. Skin state of this phenotype: oily, higher water content, good skin elasticity.
  • the skin type is M type (type III): when the ratio of the level (eg content) (M) of the Moraxella oslo to the level (eg content) (C) of the P. acnes in the sample ( M/C) meets the following conditions: M/C ⁇ 0.5, preferably, M/C ⁇ 1.8, more preferably, M/C ⁇ 2.2.
  • M/C ⁇ 0.5, preferably, M/C ⁇ 1.8, more preferably, M/C ⁇ 2.2 The skin condition of this phenotype: poor oil and water content, poor skin elasticity, and high degree of skin aging.
  • the skin type is mixed (or type II): when the ratio (M/C) of the level (eg content) (M) of the Moraxella oslo to the level (eg content) (C) of the P. acnes When the following conditions are met: 0.3 ⁇ M/C ⁇ 2.5, preferably, 0.3 ⁇ M/C ⁇ 2.3, more preferably, 0.8 ⁇ M/C ⁇ 1.8.
  • the skin state of this phenotype is between C and M types.
  • MMPs matrix metalloproteinases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

Provided in the present invention is the use of Moraxella osloensis, which is used for skin typing, characterizing skin conditions or for preparing a reagent or a kit for characterizing skin conditions. Further provided in the present invention is a marker combination, comprising the following markers: Moraxella osloensis and Propionibacterium acnes. Also provided in the present invention is the use of the marker combination in skin typing and/or judgment of skin conditions.

Description

用于皮肤分型的标志物组合及其应用Marker combination for skin typing and its application 技术领域technical field
本发明涉及生物医药领域,具体地涉及用于皮肤分型的标志物组合及其应用。The present invention relates to the field of biomedicine, in particular to a marker combination for skin typing and its application.
背景技术Background technique
随着微生物组计划的推出,人们逐渐认识到,与肠道类似,人体表面亦存在大量的微生物。肠道研究已提示微生物-宿主间的相互作用以及通过粪菌移植、益生菌、益生元的策略可改变肠道微生态,进而改善肠道稳态。皮肤微生态的研究进展相对滞后,特别缺乏大规模人群的宏基因组数据。基于北美人群的宏基因组数据提示皮肤微生物在组成上个体差异性大但稳定性高,即个体随时间空间变化其微生物组成相对稳定,具有极强的个人特征。本项研究基于中国汉人群的数据再次证实了个体差异性的存在,并发现微生物组成与宿主一系列皮肤表型存在显著关联,皮肤微生物可作为改善皮肤表型的潜在新手段、新靶点。With the introduction of the Microbiome Project, people have gradually realized that, similar to the gut, there are also a large number of microorganisms on the surface of the human body. Intestinal studies have suggested that microbiota-host interactions and strategies through fecal transplantation, probiotics, and prebiotics can alter the gut microbiome to improve gut homeostasis. The research progress of skin microecology is relatively lagging behind, especially the metagenomic data of large-scale population is lacking. Metagenomic data based on North American populations suggest that skin microbes have large individual differences in composition but high stability, that is, individuals whose microbial composition changes over time and space are relatively stable and have strong personal characteristics. Based on the data of the Chinese Han population, this study once again confirmed the existence of individual differences, and found that the microbial composition was significantly associated with a series of skin phenotypes of the host. Skin microbes can be used as potential new means and new targets to improve skin phenotypes.
然而极强的个体差异性为研发设计普适的护肤产品、药品提出了严峻挑战。通过进一步统计学分析,我们发现尽管个体差异大,但在人群水平依然存在一些主要特征和规律,通过这些特征的组合能将人群进行分型,从而解决个体差异性大的问题。皮肤分型能很好的满足低水平上(low resolution)的“精准”/“个性化”护理。例如,目前常用的一种皮肤分型——“干性”、“中性”、“油性”皮肤,即根据宿主皮肤的水油特征分型;与之类似,但不同的是我们的这项研究不是水油特征,而是基于皮肤微生物组特征,对人群进行分型。从而有助于工业界针对不同皮肤型,开发出更适合特定人群的护肤产品、药品,达到一定程度上的“精准”/“个性化”护理,有效改善皮肤稳态。However, the strong individual differences pose severe challenges to the development and design of universal skin care products and medicines. Through further statistical analysis, we found that although there are large individual differences, there are still some main characteristics and laws at the population level. The combination of these characteristics can classify the population and solve the problem of large individual differences. Skin typing is well suited for low resolution "precision"/"personalized" care. For example, one of the commonly used skin classifications - "dry", "normal", "oily" skin, is classified according to the water and oil characteristics of the host skin; similar to this, but the difference is that our Instead of water-oil signatures, the study typed populations based on skin microbiome signatures. This will help the industry to develop skin care products and medicines that are more suitable for specific groups of people for different skin types, achieve a certain degree of "precise"/"personalized" care, and effectively improve skin stability.
因此,本领域迫切需要开发新的用于皮肤分型、判断皮肤老法的方法,提供一种新的诊断、分型手段。Therefore, there is an urgent need in the art to develop new methods for skin typing and judging skin aging, and to provide a new diagnostic and typing method.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于基于皮肤微生物组特征,对人群进行分型,从而有助于工业界针对不同皮肤型,开发出更适合特定人群的护肤产品、药品。提供新的用 于皮肤分型、判断皮肤状态的方法,提供一种新的诊断、分型手段。The purpose of the present invention is to classify the population based on the characteristics of the skin microbiome, thereby helping the industry to develop skin care products and medicines that are more suitable for specific populations for different skin types. Provide a new method for skin typing and judging skin state, and provide a new diagnostic and typing method.
本发明将关注目标锁定在主导皮肤分型的两株细菌——奥斯陆莫拉菌(Moraxella osloensis)和痤疮丙酸杆菌(Cutibacterium acnes)以及在宿主的健康和疾病中扮演重要角色的、皮肤上丰富的细菌定植体之一——表皮葡萄球菌(Staphylococcus epidermidis)上。首先,在汉族人群大规模样本的宏基因组数据中,确定了三株目标皮肤共生菌在面部的分布丰度与宿主皮肤表型之间的相关性,而后进行QPCR实验验证,确定了一株可促进皮肤衰老的细菌—奥斯陆莫拉菌(M.osloensis)。The present invention will focus on the two bacteria that dominate skin typing, Moraxella osloensis and Cutibacterium acnes, as well as skin-abundant bacteria that play an important role in host health and disease. on one of the bacterial colonies of the species, Staphylococcus epidermidis. First, in the metagenomic data of large-scale samples of the Han population, the correlation between the distribution abundance of three target skin symbionts on the face and the host skin phenotype was determined. The bacteria that promote skin aging - M. osloensis.
在本发明的第一方面,提供了一种奥斯陆莫拉菌(M.osloensis)或其检测试剂的用途,用于(a)皮肤分型;和/或(b)判断或表征皮肤状态或用于制备一试剂或试剂盒,所述试剂或试剂盒用于(a)皮肤分型;和/或(b)判断或表征皮肤状态。In a first aspect of the present invention, there is provided a use of M. osloensis or a detection reagent thereof for (a) skin typing; and/or (b) judging or characterizing skin conditions or using For preparing a reagent or kit for (a) skin typing; and/or (b) determining or characterizing skin condition.
在另一优选例中,所述皮肤状态包括:皮肤年龄、皮肤含水量、皮肤弹性、皮肤颜色、皮肤衰老程度。In another preferred example, the skin condition includes: skin age, skin moisture content, skin elasticity, skin color, and skin aging degree.
在另一优选例中,基于选自下组的一种或多种表型判断皮肤的衰老程度:卟啉、油脂、含水量、光泽度、毛孔面积、皮肤黄值、毛孔大小、色斑。In another preferred embodiment, the aging degree of the skin is judged based on one or more phenotypes selected from the group consisting of porphyrin, oil, water content, gloss, pore area, skin yellowness, pore size, and pigmentation.
在另一优选例中,所述试剂或试剂盒还包括检测痤疮丙酸杆菌(C.acnes)的试剂。In another preferred embodiment, the reagent or kit further includes a reagent for detecting Propionibacterium acnes (C. acnes).
在另一优选例中,所述试剂或试剂盒还包括检测牛眼莫拉氏菌(Moraxella bovoculi)和/或冷杆菌属(Psychrobacter sp.)的试剂。In another preferred embodiment, the reagent or kit further includes a reagent for detecting Moraxella bovoculi and/or Psychrobacter sp.
在另一优选例,所述试剂或试剂盒还包括检测贪婪丙酸杆菌(Propionibacterium avidum)、颗粒丙酸杆菌(Propionibacterium granulosum)、葡萄球菌属(Staphylococcus)、痤疮丙酸噬菌体和/或葡萄球菌噬菌体的试剂。In another preferred embodiment, the reagent or kit further comprises detection of Propionibacterium avidum, Propionibacterium granulosum, Staphylococcus, Propionibacterium acnes and/or Staphylococcus phage reagent.
在另一优选例中,所述试剂或试剂盒还包括检测表皮葡萄球菌(S.epidermidis)的试剂。In another preferred embodiment, the reagent or kit further includes a reagent for detecting Staphylococcus epidermidis (S. epidermidis).
本发明第二方面提供了一种标志物组合,所述标志物组合包括奥斯陆莫拉菌(M.osloensis)和痤疮丙酸杆菌(C.acnes)。A second aspect of the present invention provides a marker combination comprising M. osloensis and C. acnes.
在另一优选例中,所述标志物组合还包括牛眼莫拉氏菌(Moraxella bovoculi)和/或冷杆菌属(Psychrobacter sp.)。In another preferred embodiment, the marker combination further includes Moraxella bovoculi and/or Psychrobacter sp..
在另一优选例中,所述标志物组合还包括贪婪丙酸杆菌(Propionibacterium avidum)、颗粒丙酸杆菌(Propionibacterium granulosum)、葡萄球菌属(Staphylococcus)、痤疮丙酸噬菌体和/或葡萄球菌噬菌体。In another preferred embodiment, the marker combination further includes Propionibacterium avidum, Propionibacterium granulosum, Staphylococcus, Propionibacterium acnes and/or Staphylococcus phage.
在另一优选例中,所述标志物组合还包括表皮葡萄球菌(S.epidermidis)。In another preferred embodiment, the marker combination further includes Staphylococcus epidermidis (S. epidermidis).
在另一优选例中,所述标志物组合用于(a)皮肤分型;和/或(b)判断皮肤状态。In another preferred embodiment, the marker combination is used for (a) skin typing; and/or (b) judging skin state.
在另一优选例中,所述皮肤状态包括:皮肤年龄、皮肤含水量、皮肤弹性、皮肤颜色、皮肤衰老程度。In another preferred example, the skin condition includes: skin age, skin moisture content, skin elasticity, skin color, and skin aging degree.
在另一优选例中,基于选自下组的一种或多种表型判断皮肤的衰老程度:卟啉、油脂、含水量、光泽度、毛孔面积、皮肤黄值、毛孔大小、色斑。In another preferred embodiment, the aging degree of the skin is judged based on one or more phenotypes selected from the group consisting of porphyrin, oil, water content, gloss, pore area, skin yellowness, pore size, and pigmentation.
在另一优选例中,所述的标志物或标志物组合来源于皮肤样品,较佳地,来源于全身皮肤或面部皮肤,更佳地,来源于面颊、额头、鼻翼。In another preferred embodiment, the marker or marker combination is derived from a skin sample, preferably from whole body skin or facial skin, more preferably from cheek, forehead, and nose.
在另一优选例中,所述标志物或标志物组合来源于亚洲人群的皮肤样品。In another preferred embodiment, the marker or marker combination is derived from skin samples of Asian population.
在另一优选例中,所述标志物或标志物组合来源于面颊、额头、鼻翼样品。In another preferred embodiment, the marker or marker combination is derived from cheek, forehead, and alar samples.
在另一优选例中,通过下组的一种或多种方法对所述标志物组合中的各个标志物的水平进行检测:测序、PCR、蛋白定量检测。In another preferred embodiment, the level of each marker in the marker combination is detected by one or more methods of the following group: sequencing, PCR, protein quantitative detection.
在另一优选例中,对所述标志物组水平检测的方法还包括选自下组的一种或多种方法:特征基因定量PCR、qPCR、实时定量PCR、宏基因组学分析、16s RNA测序、质谱分析、蛋白质免疫印迹。In another preferred embodiment, the method for detecting the level of the marker group further includes one or more methods selected from the group consisting of: quantitative PCR for characteristic genes, qPCR, real-time quantitative PCR, metagenomics analysis, 16s RNA sequencing , mass spectrometry, and western blotting.
在另一优选例中,所述标志物组合中的所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≤1.3,较佳地,M/C≤0.8,更佳地M/C≤0.4,则皮肤类型为C型(或I型),其表型包括:油脂含量高、含水量高、皮肤弹性好、皮肤衰老程度低、皮肤颜色光亮。In another preferred embodiment, the ratio (M/ C) When the following conditions are met: M/C≤1.3, preferably, M/C≤0.8, more preferably M/C≤0.4, then the skin type is type C (or type I), and its phenotype includes: oil High content, high water content, good skin elasticity, low skin aging, bright skin color.
在另一优选例中,所述标志物组合中的所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:0.3≤M/C≤2.5,较佳地,0.3≤M/C≤2.3,更佳地,0.8≤M/C≤1.8,则皮肤类型为混合型(或II型),其表型包括:油脂含量中等、含水量中等、皮肤弹性一般、皮肤衰老程度中等、皮肤颜色中等。In another preferred embodiment, the ratio (M/ C) When the following conditions are met: 0.3≤M/C≤2.5, preferably, 0.3≤M/C≤2.3, more preferably, 0.8≤M/C≤1.8, then the skin type is mixed (or type II) , and its phenotypes include: medium oil content, medium water content, average skin elasticity, moderate skin aging, and medium skin color.
在另一优选例中,所述标志物组合中的所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时: M/C≥0.5,较佳地,M/C≥1.8,更佳地,M/C≥2.2,则皮肤类型为M型(III型),其表型包括皮肤油脂含量低、含水量较低,皮肤弹性差,皮肤衰老程度高、皮肤颜色暗沉。In another preferred embodiment, the ratio (M/ C) When the following conditions are met: M/C≥0.5, preferably, M/C≥1.8, more preferably, M/C≥2.2, then the skin type is M type (type III), and its phenotype includes skin oil Low content, low water content, poor skin elasticity, high degree of skin aging, dull skin color.
在另一优选例中,来源于面颊处样本,所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≤0.8,较佳地,M/C≤0.75,则皮肤类型为C型(或I型),其表型包括油脂含量高、含水量高、皮肤弹性好、皮肤衰老程度低、皮肤颜色光亮。In another preferred example, from the cheek sample, the ratio (M/C) of the level (eg content) (M) of the Moraxella oslo to the level (eg content) (C) of the P. acnes ) when the following conditions are met: M/C≤0.8, preferably, M/C≤0.75, then the skin type is C type (or type I), and its phenotype includes high oil content, high water content, good skin elasticity, Low level of skin aging, bright skin color.
在另一优选例中,来源于面颊处样本,所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:0.75≤M/C≤2,较佳地,0.8≤M/C≤1.7,则皮肤类型为混合型(或II型),其表型包括:油脂含量中等、含水量中等、皮肤弹性一般、皮肤衰老程度中等、皮肤颜色中等。In another preferred example, from the cheek sample, the ratio (M/C) of the level (eg content) (M) of the Moraxella oslo to the level (eg content) (C) of the P. acnes ) when the following conditions are met: 0.75≤M/C≤2, preferably, 0.8≤M/C≤1.7, the skin type is mixed (or type II), and its phenotype includes: medium oil content, medium water content , The skin elasticity is average, the skin aging degree is moderate, and the skin color is moderate.
在另一优选例中,来源于面颊处样本,所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≥1.7,则皮肤类型为M型(III型),其表型包括皮肤油脂含量低、含水量较低,皮肤弹性差,皮肤衰老程度高、皮肤颜色暗沉。In another preferred example, from the cheek sample, the ratio (M/C) of the level (eg content) (M) of the Moraxella oslo to the level (eg content) (C) of the P. acnes ) when the following conditions are met: M/C≥1.7, the skin type is M type (type III), and its phenotypes include low skin oil content, low water content, poor skin elasticity, high skin aging, and dull skin color. .
在另一优选例中,对于来源于额头处样本,所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≤1.5,较佳地,M/C≤1.25,则皮肤类型为C型(或I型),其表型包括油脂含量高、含水量高、皮肤弹性好、皮肤衰老程度低、皮肤颜色光亮。In another preferred embodiment, for the sample from the forehead, the ratio (M/ C) When the following conditions are met: M/C≤1.5, preferably, M/C≤1.25, the skin type is type C (or type I), and its phenotype includes high oil content, high water content, and good skin elasticity , Low degree of skin aging, bright skin color.
在另一优选例中,来源于额头处样本,所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:1.25≤M/C≤2.5,较佳地,1.3≤M/C≤2.2,皮肤类型为混合型(或II型),其表型包括:油脂含量中等、含水量中等、皮肤弹性一般、皮肤衰老程度中等、皮肤颜色中等。In another preferred example, from the forehead sample, the ratio (M/C) of the level (eg content) (M) of the Moraxella oslo to the level (eg content) (C) of the P. acnes ) when the following conditions are met: 1.25≤M/C≤2.5, preferably, 1.3≤M/C≤2.2, the skin type is mixed (or type II), and its phenotype includes: medium oil content, medium water content, Normal skin elasticity, moderate skin aging, and moderate skin color.
在另一优选例中,来源于额头处样本,所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≥2,较佳地,≥2.2,则皮肤类型为M型(III型),其表型包括皮肤油脂含量低、含水量较低、皮肤弹性差、皮肤衰老程度高、皮肤颜色暗沉。In another preferred example, from the forehead sample, the ratio (M/C) of the level (eg content) (M) of the Moraxella oslo to the level (eg content) (C) of the P. acnes ) when the following conditions are met: M/C≥2, preferably ≥2.2, the skin type is M type (type III), and its phenotype includes low skin oil content, low water content, poor skin elasticity, and skin aging. High degree, dull skin color.
在另一优选例中,对于来源于鼻翼处样本,所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件 时:M/C≤0.5,较佳地,M/C≤0.35,皮肤类型为C型(或I型),其表型包括油脂含量高、含水量高、皮肤弹性好、皮肤衰老程度低、皮肤颜色光亮。In another preferred example, for the sample derived from the nasal wing, the ratio (M/ C) When the following conditions are met: M/C≤0.5, preferably, M/C≤0.35, the skin type is type C (or type I), and its phenotype includes high oil content, high water content, good skin elasticity, Low level of skin aging, bright skin color.
在另一优选例中,来源于鼻翼处样本,所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:0.35≤M/C≤0.7,较佳地,0.35≤M/C≤0.6,更佳地,0.35≤M/C≤0.55,皮肤类型为混合型(或II型),其表型包括:油脂含量中等、含水量中等、皮肤弹性一般、皮肤衰老程度中等、皮肤颜色中等。In another preferred example, the ratio (M/C) of the level (such as content) (M) of the Moraxella oslo to the level (such as content) (C) of the P. acnes is derived from a sample from the nose wing ) when the following conditions are met: 0.35≤M/C≤0.7, preferably, 0.35≤M/C≤0.6, more preferably, 0.35≤M/C≤0.55, the skin type is mixed type (or type II), which Phenotypes include: moderate oil content, moderate moisture content, moderate skin elasticity, moderate skin aging, and moderate skin color.
在另一优选例中,来源于鼻翼处样本,所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≥0.5,较佳地,M/C≥0.55,皮肤类型为M型(III型),其表型包括皮肤油脂含量低、含水量较低,皮肤弹性差,皮肤衰老程度高、皮肤颜色暗沉。In another preferred example, the ratio (M/C) of the level (such as content) (M) of the Moraxella oslo to the level (such as content) (C) of the P. acnes is derived from a sample from the nose wing ) when the following conditions are met: M/C≥0.5, preferably, M/C≥0.55, the skin type is M type (type III), and its phenotype includes low skin oil content, low water content, poor skin elasticity, High degree of skin aging, dull skin color.
本发明第三方面提供了一种皮肤分型或判断皮肤状态的方法,所述方法包括:A third aspect of the present invention provides a method for skin typing or judging skin state, the method comprising:
(1)提供一来源于待测对象皮肤的样品,对样品标志物组合中各个标志物的水平(如含量)进行检测,所述组合包括以下标志物:奥斯陆莫拉菌和痤疮丙酸杆菌,分别获得奥斯陆莫拉菌的水平(如含量)(M)和痤疮丙酸杆菌的水平(如含量)(C);(1) providing a sample derived from the skin of the subject to be tested, and detecting the level (such as content) of each marker in the sample marker combination, the combination including the following markers: Moraxella oslo and Propionibacterium acnes, Obtain the level (such as content) of Moraxella oslo (M) and the level (such as content) of P. acnes (C), respectively;
(2)基于奥斯陆莫拉菌的水平(如含量)(M),或将所述样品中的奥斯陆莫拉菌的水平(如含量)(M)与痤疮丙酸杆菌的水平(如含量)(C)进行比较,从而对待测对象的皮肤进行分型、和/或判断皮肤状态。(2) Based on the level (such as content) (M) of Moraxella oslo, or comparing the level (such as content) (M) of Moraxella oslo in the sample with the level (such as content) of P. acnes ( C) to compare, so as to classify the skin of the object to be tested, and/or to judge the skin state.
在另一优选例中,所述待测对象来源于亚洲人群。In another preferred embodiment, the subject to be tested is from an Asian population.
在另一优选例中,步骤(2)中,根据奥斯陆莫拉菌的水平(如含量)(M)与痤疮丙酸杆菌的水平(如含量)(C)的相对值(比如M/C)对皮肤进行分型,或判断样本的皮肤状态。In another preferred example, in step (2), according to the relative value (such as M/C) of the level (such as content) (M) of Moraxella oslo and the level (such as content) (C) of P. acnes Type the skin, or determine the skin condition of a sample.
在另一优选例中,所述的皮肤状态包括皮肤年龄、皮肤含水量、皮肤弹性、皮肤颜色、皮肤衰老程度。In another preferred example, the skin condition includes skin age, skin moisture content, skin elasticity, skin color, and skin aging degree.
在另一优选例中,用选自下组的一种或多种方法对待测对象的样品中的奥斯陆莫拉菌的水平(如含量)(M)和痤疮丙酸杆菌的水平(如含量)(C)进行确定:测序、PCR、蛋白定量检测。In another preferred embodiment, the level (eg content) (M) of Moraxella oslo and the level (eg content) of P. acnes in the sample of the subject to be tested by one or more methods selected from the following group (C) Confirmation: sequencing, PCR, protein quantitative detection.
在另一优选例中,对所述样品中的奥斯陆莫拉菌的水平(如含量)(M)和痤 疮丙酸杆菌的水平(如含量)(C)的检测方法还包括选自下组的一种或多种方法:特征基因定量PCR、qPCR、实时定量PCR、宏基因组学分析、16s RNA测序、质谱分析、蛋白质免疫印迹。In another preferred embodiment, the method for detecting the level (eg content) (M) of Moraxella oslo and the level (eg content) (C) of Propionibacterium acnes in the sample further comprises a method selected from the group consisting of: One or more methods: quantitative PCR for signature genes, qPCR, real-time quantitative PCR, metagenomics analysis, 16s RNA sequencing, mass spectrometry, Western blotting.
在另一优选例中,所述样品中的所述奥斯陆莫拉菌的(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≤1.3,较佳地,M/C≤0.8,更佳的M/C≤0.4,则皮肤类型为C型(或I型),其表型包括:油脂含量高、含水量高、皮肤弹性好、皮肤衰老程度低、皮肤颜色光亮。In another preferred example, the ratio (M/C) of the Moraxella oslo (M) to the level (such as content) (C) of the P. acnes in the sample meets the following conditions: M/C≤1.3, preferably, M/C≤0.8, more preferably M/C≤0.4, then the skin type is C type (or type I), and its phenotype includes: high oil content, high water content, Good skin elasticity, low skin aging, bright skin color.
在另一优选例中,所述样品中的所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:0.3≤M/C≤2.5,较佳地,0.3≤M/C≤2.3,更佳地,0.8≤M/C≤1.8,则皮肤类型为混合型(或II型),其表型包括:油脂含量中等、含水量中等、皮肤弹性一般、皮肤衰老程度中等、皮肤颜色中等。In another preferred example, the ratio (M/C) of the level (eg content) (M) of the Moraxella oslo in the sample to the level (eg content) (C) of the P. acnes When the following conditions are met: 0.3≤M/C≤2.5, preferably, 0.3≤M/C≤2.3, more preferably, 0.8≤M/C≤1.8, then the skin type is mixed (or type II), and its Phenotypes include: moderate oil content, moderate moisture content, moderate skin elasticity, moderate skin aging, and moderate skin color.
在另一优选例中,所述样品中的所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≥0.5,较佳地,M/C≥1.8,更佳地,M/C≥2.2,则皮肤类型为M型(III型),其表型包括皮肤油脂含量低、含水量较低、皮肤弹性差、皮肤衰老程度高、皮肤颜色暗沉。In another preferred example, the ratio (M/C) of the level (eg content) (M) of the Moraxella oslo in the sample to the level (eg content) (C) of the P. acnes When the following conditions are met: M/C≥0.5, preferably, M/C≥1.8, more preferably, M/C≥2.2, the skin type is M type (type III), and its phenotype includes low skin oil content , low water content, poor skin elasticity, high degree of skin aging, dull skin color.
在另一优选例中,来源于面颊处样本,所述样品中的奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≤0.8,较佳地,M/C≤0.75,则皮肤类型为C型(或I型),其表型包括油脂含量高、含水量高、皮肤弹性好、皮肤衰老程度低、皮肤颜色光亮。In another preferred embodiment, the sample is derived from the cheek, and the ratio of the level (such as content) (M) of Moraxella oslo in the sample to the level (such as content) (C) of Propionibacterium acnes ( When M/C) meets the following conditions: M/C≤0.8, preferably, M/C≤0.75, then the skin type is C type (or type I), and its phenotype includes high oil content, high water content, skin Good elasticity, low skin aging, bright skin color.
在另一优选例中,来源于面颊处样本,所述样品中的奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:0.75≤M/C≤2,较佳地,0.8≤M/C≤1.7,则皮肤类型为混合型(或II型),其表型包括:油脂含量中等、含水量中等、皮肤弹性一般、皮肤衰老程度中等、皮肤颜色中等。In another preferred embodiment, the sample is derived from the cheek, and the ratio of the level (such as content) (M) of Moraxella oslo in the sample to the level (such as content) (C) of Propionibacterium acnes ( When M/C) meets the following conditions: 0.75≤M/C≤2, preferably, 0.8≤M/C≤1.7, then the skin type is mixed type (or type II), and its phenotype includes: medium oil content, Moderate moisture content, average skin elasticity, moderate skin aging, and moderate skin tone.
在另一优选例中,来源于面颊处样本,所述样品中的奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≥1.7,则皮肤类型为M型(III型),其表型包括皮肤油脂含量低、含水量较低、皮肤弹性差、皮肤衰老程度高、皮肤颜色暗沉。In another preferred embodiment, the sample is derived from the cheek, and the ratio of the level (such as content) (M) of Moraxella oslo in the sample to the level (such as content) (C) of Propionibacterium acnes ( When M/C) meets the following conditions: M/C≥1.7, the skin type is M type (type III), and its phenotypes include low skin oil content, low water content, poor skin elasticity, high skin aging, and skin Dull in color.
在另一优选例中,对于来源于额头处样本,所述样品中的奥斯陆莫拉菌的 水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≤1.5,较佳地,M/C≤1.25,则皮肤类型为C型(或I型),其表型包括油脂含量高、含水量高、皮肤弹性好、皮肤衰老程度低、皮肤颜色光亮。In another preferred example, for a sample from the forehead, the ratio of the level (eg content) (M) of Moraxella oslo in the sample to the level (eg content) (C) of Propionibacterium acnes (M/C) When the following conditions are met: M/C≤1.5, preferably, M/C≤1.25, then the skin type is C type (or type I), and its phenotype includes high oil content, high water content, Good skin elasticity, low skin aging, bright skin color.
在另一优选例中,来源于额头处样本,所述样品中的奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:1.25≤M/C≤2.5,较佳地,1.3≤M/C≤2.2,皮肤类型为混合型(或II型),其表型包括:油脂含量中等、含水量中等、皮肤弹性一般、皮肤衰老程度中等、皮肤颜色中等。In another preferred embodiment, the sample is derived from the forehead, the ratio of the level (eg content) (M) of Moraxella oslo in the sample to the level (eg content) (C) of Propionibacterium acnes ( M/C) when the following conditions are met: 1.25≤M/C≤2.5, preferably, 1.3≤M/C≤2.2, the skin type is mixed (or type II), and its phenotype includes: medium oil content, high The amount of water is medium, the skin elasticity is average, the skin aging is medium, and the skin color is medium.
在另一优选例中,来源于额头处样本,所述样品中的奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≥2,较佳地,≥2.2,则皮肤类型为M型(III型),其表型包括皮肤油脂含量低、含水量较低、皮肤弹性差、皮肤衰老程度高、皮肤颜色暗沉。In another preferred embodiment, the sample is derived from the forehead, the ratio of the level (eg content) (M) of Moraxella oslo in the sample to the level (eg content) (C) of Propionibacterium acnes ( When M/C) meets the following conditions: M/C ≥ 2, preferably ≥ 2.2, the skin type is M type (type III), and its phenotype includes low skin oil content, low water content, and poor skin elasticity , High degree of skin aging, dull skin color.
在另一优选例中,对于来源于鼻翼处样本,所述样品中的奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≤0.5,较佳地,M/C≤0.35,皮肤类型为C型(或I型),其表型包括油脂含量高、含水量高、皮肤弹性好、皮肤衰老程度低、皮肤颜色光亮。In another preferred example, for a sample derived from the nose wing, the ratio of the level (eg content) (M) of Moraxella oslo in the sample to the level (eg content) (C) of Propionibacterium acnes (M/C) When the following conditions are met: M/C≤0.5, preferably, M/C≤0.35, the skin type is type C (or type I), and its phenotype includes high oil content, high water content, skin Good elasticity, low skin aging, bright skin color.
在另一优选例中,来源于鼻翼处样本,所述样品中的奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:0.35≤M/C≤0.7,较佳地,0.35≤M/C≤0.6,更佳地,0.35≤M/C≤0.55,皮肤类型为混合型(或II型),其表型包括:油脂含量中等、含水量中等、皮肤弹性一般、皮肤衰老程度中等、皮肤颜色中等。In another preferred embodiment, it is derived from a sample from the nose wing, and the ratio of the level (such as content) (M) of Moraxella oslo in the sample to the level (such as content) (C) of Propionibacterium acnes ( When M/C) meets the following conditions: 0.35≤M/C≤0.7, preferably, 0.35≤M/C≤0.6, more preferably, 0.35≤M/C≤0.55, the skin type is mixed (or type II) ), and their phenotypes include: medium oil content, medium water content, average skin elasticity, moderate skin aging, and medium skin color.
在另一优选例中,来源于鼻翼处样本,所述样品中的奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≥0.5,较佳地,M/C≥0.55,皮肤类型为M型(III型),其表型包括皮肤油脂含量低、含水量较低、皮肤弹性差、皮肤衰老程度高、皮肤颜色暗沉。In another preferred embodiment, it is derived from a sample from the nose wing, and the ratio of the level (such as content) (M) of Moraxella oslo in the sample to the level (such as content) (C) of Propionibacterium acnes ( M/C) when the following conditions are met: M/C≥0.5, preferably, M/C≥0.55, the skin type is M type (type III), and its phenotype includes low skin oil content, low water content, skin Poor elasticity, high degree of skin aging, dull skin color.
在另一优选例中,所述相对值符合如下条件:M/C≤1.3时皮肤为C型,M/C≥0.5时皮肤为M型。In another preferred example, the relative value meets the following conditions: when M/C≤1.3, the skin is type C, and when M/C≥0.5, the skin is type M.
在另一优选例中,所述相对值符合如下条件:0.3≤M/C≤2.5时皮肤为混合型。In another preferred example, the relative value meets the following condition: when 0.3≤M/C≤2.5, the skin is of mixed type.
在另一优选例中,所述奥斯陆莫拉菌的水平(如含量)(M)提高时,则表明皮肤状态为皮肤年龄增加、肤色发黑发黄,皮肤含水量降低、皮脂以及卟啉 含量降低。In another preferred example, when the level (such as content) (M) of the Moraxella oslo increases, it indicates that the skin condition is increased skin age, dark and yellow complexion, reduced skin moisture content, sebum and porphyrin content reduce.
本发明第四方面提供了一种皮肤分型和/或检测皮肤状态的试剂组合,所述试剂组合包括用于检测本发明第二方面所述的组合中各个标志物的试剂。The fourth aspect of the present invention provides a reagent combination for skin typing and/or skin condition detection, the reagent combination comprising reagents for detecting each marker in the combination described in the second aspect of the present invention.
在另一优选例中,所述试剂用于检测各个标志物的水平(如含量)。In another preferred embodiment, the reagent is used to detect the level (eg content) of each marker.
在另一优选例中,所述试剂包括用选自下组的一种或多种方法检测本发明第二方面所述的组合中各个标志物的水平的物质:测序、PCR、蛋白定量检测。In another preferred embodiment, the reagent includes a substance for detecting the level of each marker in the combination described in the second aspect of the present invention by one or more methods selected from the group consisting of sequencing, PCR, and quantitative protein detection.
在另一优选例中,对所述标志物水平的检测的方法还包括:特征基因定量PCR、qPCR、实时定量PCR、宏基因组学分析、16s RNA测序、质谱分析、蛋白质免疫印迹。In another preferred embodiment, the method for detecting the marker level further includes: quantitative PCR of characteristic genes, qPCR, real-time quantitative PCR, metagenomic analysis, 16s RNA sequencing, mass spectrometry analysis, and western blotting.
在另一优选例中,所述试剂组合包括:In another preferred embodiment, the reagent combination includes:
第一检测试剂,所述第一检测试剂用于检测奥斯陆莫拉菌的水平(M);和/或A first detection reagent for detecting the level (M) of Moraxella oslo; and/or
第二检测试剂,所述第二检测试剂用于检测痤疮丙酸杆菌的水平(C)。A second detection reagent for detecting the level of P. acnes (C).
本发明第五方面提供了一种试剂盒,所述的试剂盒包括本发明第二方面所述的试剂组合。A fifth aspect of the present invention provides a kit comprising the reagent combination described in the second aspect of the present invention.
在另一优选例中,本发明第二方面所述的组合中各个标记物用作标准品。In another preferred embodiment, each marker in the combination described in the second aspect of the present invention is used as a standard.
本发明第六方面提供了一种对待测对象的皮肤进行分型和/或判断待测对象的皮肤状态的系统,所述系统包括:A sixth aspect of the present invention provides a system for classifying the skin of an object to be tested and/or judging the skin state of the object to be tested, the system comprising:
(a)特征接收模块,所述特征接收模块用于接收皮肤样本特征数据;所述的特征数据包括:皮肤样本中的奥斯陆莫拉菌(M)和痤疮丙酸杆菌(C)各自的定量信息;(a) a feature receiving module, the feature receiving module is used for receiving skin sample feature data; the feature data includes: the quantitative information of each of Moraxella oslo (M) and P. acnes (C) in the skin sample ;
(b)计算处理模块,用于计算来自所述特征接收模块的特征数据,从而获得各个特征各自的比例或各个特征之间的比例关系;并且基于所获得的各自的比例或各个特征之间的比例关系,与皮肤分型或特征表征的标准值进行比较,从而得出皮肤分型和/或皮肤状态的判断结果;和(b) a calculation processing module for calculating the feature data from the feature receiving module, so as to obtain the respective proportions of the respective features or the proportional relationship between the respective features; and based on the obtained respective proportions or the relationship between the respective features A proportional relationship, compared with a standard value for skin type or characterization, resulting in a judgment of skin type and/or skin condition; and
(c)结果输出模块,所述输出模块用于接收并输出判断结果。(c) a result output module, the output module is used for receiving and outputting the judgment result.
在另一优选例中,所述的对象是人。In another preferred embodiment, the subject is a human.
在另一优选例中,所述对象为亚洲人群。In another preferred embodiment, the subject is an Asian population.
在另一优选例中,所述对象包括男人和女人。In another preferred embodiment, the objects include men and women.
在另一优选例中,所述的对象包括婴幼儿、青少年或成年人。In another preferred embodiment, the subject includes infants, adolescents or adults.
在另一优选例中,所述定量信息包括奥斯陆莫拉菌(M)和痤疮丙酸杆菌(C)各自的水平(如含量)。In another preferred embodiment, the quantitative information includes the respective levels (eg content) of Moraxella oslo (M) and Propionibacterium acnes (C).
在另一优选例中,所述比例关系包括皮肤样本中的奥斯陆莫拉菌(M)和痤疮丙酸杆菌(C)各自水平(如含量)的相对值,比如M/C。In another preferred embodiment, the proportional relationship includes the relative values of the respective levels (eg contents) of Moraxella oslo (M) and Propionibacterium acnes (C) in the skin sample, such as M/C.
在另一优选例中,所述系统可对皮肤状态至少分为两型。In another preferred embodiment, the system can be divided into at least two types according to the skin condition.
在另一优选例中,所述定量信息的获取方法包括:测序、PCR、蛋白定量检测。In another preferred embodiment, the method for obtaining the quantitative information includes: sequencing, PCR, and quantitative protein detection.
在另一优选例中,所述定量信息的获取方法还包括:特征基因定量PCR、qPCR、实时定量PCR、宏基因组学分析、16s RNA测序、质谱分析、蛋白质免疫印迹。In another preferred embodiment, the method for obtaining the quantitative information further includes: quantitative PCR for characteristic genes, qPCR, real-time quantitative PCR, metagenomics analysis, 16s RNA sequencing, mass spectrometry analysis, and western blotting.
在另一优选例中,所述的特征接收模块包括样本采集仪、特征信号输入端。In another preferred embodiment, the feature receiving module includes a sample collector and a feature signal input end.
在另一优选例中,所述的计算处理模块包括一处理器,以及一储存器,其中所述的储存器中存储有皮肤型和/或皮肤状态的阈值信息。In another preferred embodiment, the calculation processing module includes a processor and a storage, wherein the storage stores threshold information of skin type and/or skin state.
在另一优选例中,所述的输出模块包括任何终端,优选显示器、打印机、平板电脑(PAD)、智能手机。In another preferred embodiment, the output module includes any terminal, preferably a display, a printer, a tablet computer (PAD), and a smart phone.
在另一优选例中,所述的各模块通过有线或无线方式连接。In another preferred embodiment, the modules are connected in a wired or wireless manner.
本发明第七方面提供了一种筛选改善皮肤状态物质或成分的方法,包括:A seventh aspect of the present invention provides a method for screening substances or ingredients for improving skin condition, comprising:
(a)提供一筛选菌,所述筛选菌是奥斯陆莫拉菌(M)、痤疮丙酸杆菌(C)、或包含奥斯陆莫拉菌和/或痤疮丙酸杆菌的筛选菌(混合菌);(a) providing a screening bacteria, the screening bacteria is Moraxella oslo (M), P. acnes (C), or screening bacteria (mixed bacteria) comprising Moraxella oslo and/or P. acnes;
(b)将待筛选的物质或成分与所述筛选菌进行共培养,并检测奥斯陆莫拉菌或痤疮丙酸杆菌各自的水平(如含量);或奥斯陆莫拉菌与痤疮丙酸杆菌之间的相对水平(如相对含量)(M/C);(b) co-culturing the substance or component to be screened with the screening bacteria, and detecting the respective levels (eg content) of Moraxella oslo or P. acnes; or between Moraxella oslo and P. acnes The relative level (such as relative content) (M/C);
(c)根据(b)培养后奥斯陆莫拉菌或痤疮丙酸杆菌各自的水平(如含量);或奥斯陆莫拉菌与痤疮丙酸杆菌之间的相对水平(如相对含量)(M/C),从而判断所述待筛选的物质或成分为改善皮肤状态物质或成分。(c) According to (b) the respective levels (such as content) of Moraxella oslo or P. acnes after culture; or the relative level (such as relative content) between Moraxella oslo and P. acnes (M/C ), thereby judging that the substance or ingredient to be screened is a substance or ingredient that improves skin condition.
在另一优选例中,当奥斯陆莫拉菌的含量或奥斯陆莫拉菌与痤疮丙酸杆菌之间的相对水平(如相对含量)(M/C)提高时,则表明所述待筛选的物质或成分为用于治疗痤疮的物质。In another preferred example, when the content of Moraxella oslo or the relative level (such as relative content) (M/C) between Moraxella oslo and P. acnes increases, it indicates the substance to be screened Or the ingredients are substances used to treat acne.
在另一优选例中,当奥斯陆莫拉菌的水平(如含量)下降或奥斯陆莫拉菌与痤疮丙酸杆菌之间的相对水平(如相对含量)(M/C)下降时,则表明所述待筛选的物质或成分为皮肤抗衰老物质。In another preferred example, when the level (such as content) of Moraxella oslo decreases or the relative level (such as relative content) (M/C) between Moraxella oslo and P. acnes decreases, it indicates that the The substances or ingredients to be screened are skin anti-aging substances.
在另一优选例中,当痤疮丙酸杆菌的水平(如含量)提高或痤疮丙酸杆菌与奥斯陆莫拉菌之间的相对水平(如相对含量)(C/M)提高时,则表明所述待筛选的物质或成分为皮肤抗衰老物质。In another preferred example, when the level (such as content) of P. acnes increases or the relative level (such as relative content) (C/M) between P. acnes and Moraxella oslo increases, it indicates that the The substances or ingredients to be screened are skin anti-aging substances.
在另一优选例中,当痤疮丙酸杆菌的水平(如含量)降低或痤疮丙酸杆菌与奥斯陆莫拉菌之间的相对水平(如相对含量)(C/M)降低时,则表明所述待筛选的物质或成分为用于治疗痤疮的物质。In another preferred example, when the level (such as content) of P. acnes decreases or the relative level (such as relative content) (C/M) between P. acnes and Moraxella oslo decreases, it indicates that the The substance or ingredient to be screened is a substance for treating acne.
本发明第八方面提供了一种本发明第二方面所述的标志物组合或本发明第四方面所述的试剂组合的用途,用于制备一试剂盒,所述试剂盒用于(a)皮肤分型;和/或(b)判断或表征皮肤状态。The eighth aspect of the present invention provides a use of the marker combination according to the second aspect of the present invention or the reagent combination according to the fourth aspect of the present invention, for preparing a kit for use in (a) skin typing; and/or (b) judging or characterizing skin condition.
本发明第九方面提供了一种本发明第二方面所述的标志物组合或本发明第四方面所述的试剂组合的用途,用于筛选改善皮肤状态的物质或成分。The ninth aspect of the present invention provides the use of the combination of markers described in the second aspect of the present invention or the combination of reagents described in the fourth aspect of the present invention for screening substances or components that improve skin condition.
应理解,在本发明范围内中,本发明的上述各技术特征和在下文(如实施例)中具体描述的各技术特征之间都可以互相组合,从而构成新的或优选的技术方案。限于篇幅,在此不再一一累述。It should be understood that within the scope of the present invention, the above-mentioned technical features of the present invention and the technical features specifically described in the following (eg, the embodiments) can be combined with each other to form new or preferred technical solutions. Due to space limitations, it is not repeated here.
附图说明Description of drawings
图1显示了采样皮肤部位示意图。Figure 1 shows a schematic diagram of the sampled skin site.
图2显示了汉族人群面部皮肤的微生物组成。Figure 2 shows the microbial composition of the facial skin of the Han population.
图3显示了不同部位最佳聚类数分析。Figure 3 shows the analysis of the optimal number of clusters for different parts.
图4A、B显示了额头的聚类结果,其中的箱型图分别表示两组组内样本间的平均距离,红线代表不同组样本间的平均距离。4A是JS散度(Jensen-Shannon divergence),4B是Bray-Curtis相异度(Bray-Curtis dissimilarity)。Figure 4A and B show the clustering results of the forehead, where the box plots represent the average distance between samples in the two groups, respectively, and the red line represents the average distance between samples in different groups. 4A is the JS divergence (Jensen-Shannon divergence), 4B is the Bray-Curtis dissimilarity (Bray-Curtis dissimilarity).
图4C、D显示了额头的痤疮丙酸杆菌或奥斯陆莫拉菌的相对水平,每个点代表一个样本。Figure 4C,D show the relative levels of P. acnes or M. oslo on the forehead, with each dot representing a sample.
图4E、F显示了脸颊的聚类结果,其中的箱型图分别表示两组组内样本间的平均距离,红线代表不同组样本间的平均距离。4E是JS散度(Jensen-Shannon divergence),4F是Bray-Curtis相异度(Bray-Curtis dissimilarity)。Figure 4E and F show the clustering results of cheeks, where the box plots represent the average distance between samples in the two groups, respectively, and the red line represents the average distance between samples in different groups. 4E is JS divergence (Jensen-Shannon divergence), 4F is Bray-Curtis dissimilarity (Bray-Curtis dissimilarity).
图4G、H显示了脸颊的痤疮丙酸杆菌或奥斯陆莫拉菌的相对水平,每个点代表一个样本。Figures 4G,H show relative levels of P. acnes or M. oslo in cheeks, with each dot representing a sample.
图4I、J显示了鼻翼的聚类结果,其中的箱型图分别表示两组组内样本间的平均距离,红线代表不同组样本间的平均距离。4I是JS散度(Jensen-Shannon divergence),4J是Bray-Curtis相异度(Bray-Curtis dissimilarity)。Figure 4I and J show the clustering results of the nose ala, where the box plots represent the average distance between samples in the two groups, respectively, and the red line represents the average distance between samples in different groups. 4I is the JS divergence (Jensen-Shannon divergence), 4J is the Bray-Curtis dissimilarity (Bray-Curtis dissimilarity).
图4K、L显示了鼻翼的痤疮丙酸杆菌或奥斯陆莫拉菌的相对水平,每个点代表一个样本。Figure 4K,L show the relative levels of P. acnes or M. oslo in the nasal ala, with each dot representing a sample.
图5显示了不同皮肤型间的差异微生物,颜色代表微生物的相对水平,每一列为一个样本,每一行为一种微生物。Figure 5 shows the differential microorganisms between different skin types, with colors representing the relative levels of microorganisms, one sample per column and one microorganism per row.
图6显示了不同皮肤型的微生物网络特征,左侧为M-cutotype富集的微生物种类,右侧为C-cutotype富集的微生物种类。每个点代表一个种,每个颜色的花束代表一个种。由图可见一种皮肤型内部富集微生物相互间呈正相关,与另一皮肤型的富集物种呈负相关,不同的皮肤型展现出不同的微生物网络构成。Figure 6 shows the microbial network characteristics of different skin types, with M-cutotype-enriched microbial species on the left and C-cutotype-enriched microbial species on the right. Each dot represents a species, and each color of the bouquet represents a species. It can be seen from the figure that the enriched microorganisms in one skin type are positively correlated with each other and negatively correlated with the enriched species of another skin type. Different skin types show different microbial network compositions.
图7显示了不同皮肤型皮肤微生物基因的功能富集差异。Figure 7 shows the differences in functional enrichment of skin microbial genes for different skin types.
图8显示了不同皮肤型间的表型差异。Figure 8 shows phenotypic differences between different skin types.
图9显示了奥斯陆莫拉菌与年龄以及皮肤表型之间的相关性分析:校正后P值小于0.05。Figure 9 shows the correlation analysis between Moraxella oslo and age and skin phenotype: adjusted P value is less than 0.05.
图10显示了aceA/aceB基因富集于M-Cutotype。Figure 10 shows that aceA/aceB genes are enriched in M-Cutotype.
图11显示了beta-Carotene合成通路富集于M-Cutotype。Figure 11 shows that the beta-Carotene synthesis pathway is enriched for M-Cutotype.
图12显示了奥斯陆莫拉菌上清液和空白对照组处理人角质形成细胞HaCaT的RNAseq差异表达基因的功能富集分析。Figure 12 shows the functional enrichment analysis of RNAseq differentially expressed genes in human keratinocyte HaCaT treated with Moraxella oslo supernatant and blank control group.
图13显示了奥斯陆莫拉菌对多种水溶性碳源化合物的利用。左图为CCK-8试剂盒测得,右图为Dye mix A测得。Figure 13 shows the utilization of various water-soluble carbon source compounds by Moraxella oslo. The left picture is measured by CCK-8 kit, and the right picture is measured by Dye mix A.
图14显示了利用新加坡华人皮肤宏基因组数据验证皮肤型的结果。Figure 14 shows the results of skin type validation using Singapore Chinese skin metagenomic data.
图15显示了利用菲律宾、意大利皮肤宏基因组数据验证皮肤型的结果。Figure 15 shows the results of skin type validation using Philippine and Italian skin metagenomic data.
图16显示了三株皮肤共生菌的物种水平与宿主表型之间的相关性热图。Figure 16 shows a heatmap of the correlation between species level and host phenotype of three dermatosymbionts.
图17显示了奥斯陆莫拉菌-HaCaT-QPCR结果图。Figure 17 shows a graph of Moraxella oslo-HaCaT-QPCR results.
图18显示了痤疮丙酸杆菌-HaCaT-QPCR结果图。Figure 18 shows a graph of P. acnes-HaCaT-QPCR results.
图19显示了表皮葡萄球菌-HaCaT-QPCR结果图。Figure 19 shows a graph of S. epidermidis-HaCaT-QPCR results.
具体实施方式Detailed ways
本发明人经过广泛而深入地研究,首次发现奥斯陆莫拉菌可用于表征皮肤状态或用于皮肤分型,并且本发明还首次发现了一种新的标志物组合:奥斯陆莫拉菌和痤疮丙酸杆菌。本发明的标志物组合可(a)皮肤分型;和/或(b)判断皮肤 状态,具有高灵敏性、高特异性的优点,具有重要的应用价值。在此基础上,发明人完成了本发明。After extensive and in-depth research, the inventors found that Moraxella oslo can be used to characterize skin conditions or for skin typing for the first time, and the present invention also discovered a new marker combination for the first time: Moraxella oslo and C. acnes Acidobacter. The marker combination of the present invention can (a) classify the skin; and/or (b) judge the skin state, has the advantages of high sensitivity and high specificity, and has important application value. On this basis, the inventors have completed the present invention.
术语the term
本发明所用术语具有相关领域普通技术人员通常理解的含义。然而,为了更好地理解本发明,对一些定义和相关术语的解释如下:Terms used herein have the meanings commonly understood by those of ordinary skill in the relevant art. However, for a better understanding of the present invention, some definitions and related terms are explained as follows:
根据本发明,术语“标志物组合”是指两种及两种以上标志物的组合。According to the present invention, the term "marker combination" refers to a combination of two or more markers.
根据本发明,标志物质的水平通过两种微生物的存在含量和/或表现量的比值确定。According to the present invention, the level of the marker substance is determined by the ratio of the presence and/or expression of the two microorganisms.
根据本发明,术语“个体”指动物,特别是哺乳动物,如灵长类动物,最好是人。According to the present invention, the term "individual" refers to animals, especially mammals, such as primates, preferably humans.
根据本发明,术语如“一”、“一个”和“这”不仅指单数的个体,而是包括可以用来说明特定实施方式的通常的一类。In accordance with the present invention, terms such as "a," "an," and "the" do not refer only to the singular, but include the general class that may be used to describe particular embodiments.
如本文所用,在提到具体列举的数值中使用时,术语“约”意指该值可以从列举的值变动不多于1%。例如,如本文所用,表述“约100”包括99和101和之间的全部值(例如,99.1、99.2、99.3、99.4等)。As used herein, when used in reference to a specifically recited value, the term "about" means that the value may vary by no more than 1% from the recited value. For example, as used herein, the expression "about 100" includes all values between 99 and 101 and (eg, 99.1, 99.2, 99.3, 99.4, etc.).
如本文所用,术语“含有”或“包括(包含)”可以是开放式、半封闭式和封闭式的。换言之,所述术语也包括“基本上由…构成”、或“由…构成”。As used herein, the terms "containing" or "including (including)" can be open, semi-closed, and closed. In other words, the term also includes "consisting essentially of," or "consisting of."
需要说明的是,在此提供术语的解释仅为了使本领域技术人员更好地理解本发明,并非对本发明限制。It should be noted that the explanations of terms provided here are only for the purpose of enabling those skilled in the art to better understand the present invention, rather than limiting the present invention.
奥斯陆莫拉菌,Moraxella Osloensis,M.osloensis,后面简称M菌Moraxella Osloensis, M.osloensis, hereinafter referred to as M bacteria
奥斯陆莫拉菌,莫拉菌属,杆菌,革兰氏阴性,化能有机营养菌。不能利用碳水化合物产酸。Moraxella oslo, Moraxella spp., bacilli, gram-negative, chemoorganotrophic bacteria. Can not use carbohydrates to produce acid.
痤疮丙酸杆菌,Cutibacterium acnes,C.acnes,后面简称C菌Propionibacterium acnes, Cutibacterium acnes, C. acnes, hereinafter referred to as C bacteria
痤疮丙酸杆菌,放线菌门放线菌纲放线菌目丙酸杆菌科丙酸杆菌属的一种,为革兰氏阳性杆菌。人类皮肤重要的定植菌,参与维持皮肤健康,也可作为寻常痤疮的病原菌。Propionibacterium acnes, a gram-positive bacillus, is a genus of Propionibacterium in the Actinomycete Actinomycete Actinomycetales. Important colonizer of human skin, involved in maintaining skin health, and can also act as a causative agent of acne vulgaris.
表皮葡萄球菌,Staphylococcus epidermidis,S.epidermidisStaphylococcus epidermidis, Staphylococcus epidermidis, S. epidermidis
是滋生于生物体表皮上的一种革兰氏阳性球菌,存在于人体的皮肤,阴道等部位,因常堆聚成葡萄串状,故命名为表皮葡萄球菌。It is a gram-positive coccus that breeds on the epidermis of organisms. It exists in the skin, vagina and other parts of the human body. Because it often accumulates into grape clusters, it is named Staphylococcus epidermidis.
皮肤分型skin type
在本发明中,可将皮肤进一步分为M-Cutotype型(简称M型)、混合型、C-Cutotype型(简称C型)。In the present invention, the skin can be further classified into M-Cutotype type (referred to as M type), mixed type, and C-Cutotype type (referred to as C type).
C-CutotypeC-Cutotype
如本文所用,术语“C-Cutotype”、“C型”可互换使用,是指基于微生物的皮肤分型中的一种类型,其特征为高水平聚集痤疮丙酸杆菌(C.acnes)。As used herein, the terms "C-Cutotype", "C-type" are used interchangeably and refer to a type of microbe-based skin typing characterized by high levels of aggregation of P. acnes (C. acnes).
M-CutotypeM-Cutotype
如本文所用,术语“M-Cutotype”、“M型”可互换使用,是指基于微生物的皮肤分型中的一种类型,其特征为高水平聚集奥斯陆莫拉菌(M.osloensis)。As used herein, the terms "M-Cutotype", "M-type" are used interchangeably and refer to a type of microbe-based skin typing characterized by high levels of aggregation of M. osloensis.
皮肤弹性skin elasticity
如本文所用,皮肤弹性取决但不限于皮肤含水量、胶原蛋白、弹性蛋白和天然脂肪等含量是否充足。As used herein, skin elasticity depends on, but is not limited to, the adequacy of skin moisture, collagen, elastin, and natural fats, among others.
皮肤颜色skin color
如本文所用,皮肤颜色取决但不限于皮肤光泽度、皮肤肤色、黄值等。As used herein, skin color depends on, but is not limited to, skin radiance, skin tone, yellowness, and the like.
皮肤衰老程度degree of skin aging
如本文所用,皮肤衰老取决但不限于皮肤卟啉增加,皮肤含水量及光泽度下降,毛孔变大且面积增大、皮肤油脂不平衡以及皮肤暗沉等现象。As used herein, skin aging depends on, but is not limited to, increased skin porphyrins, decreased skin moisture content and radiance, enlarged and enlarged pores, skin oil imbalance, and dull skin.
检测方法Detection method
利用采集器,例如无菌棉签,蘸取采菌液,反复摩擦采菌部位,获得微生物样本。通过常见的分子生物学手段对可表征M菌或C菌的水平(如含量)进行检查,例如以下方式可获得M/C比例:1.16sRNA测序;2.宏基因组测序; 3.针对两物种特征序列设计引物,再使用qPCR可获得M/C比例;4.对两种菌的特异表达蛋白或代谢产物进行检测达到定量的目的,例如质谱分析、蛋白质免疫印迹等。Use a collector, such as a sterile cotton swab, to dip the bacterial solution, and repeatedly rub the bacterial sampling site to obtain a microbial sample. The level (such as content) that can characterize M bacteria or C bacteria is checked by common molecular biology methods. For example, the M/C ratio can be obtained in the following ways: 1. 16sRNA sequencing; 2. Metagenome sequencing; 3. Characteristics of two species Sequence design primers, and then use qPCR to obtain the M/C ratio; 4. Detect the specific expressed proteins or metabolites of the two bacteria for quantitative purposes, such as mass spectrometry analysis, Western blotting, etc.
试剂盒Reagent test kit
在本发明中,本发明的试剂盒包括本发明第二方面所述的组合和/或本发明第四方面所述的试剂组合。In the present invention, the kit of the present invention includes the combination described in the second aspect of the present invention and/or the reagent combination described in the fourth aspect of the present invention.
在另一优选例中,本发明第一方面所述的组合中各个标志物用作标准品。In another preferred embodiment, each marker in the combination described in the first aspect of the present invention is used as a standard.
本发明的主要优点包括:The main advantages of the present invention include:
(1)本发明以奥斯陆莫拉菌和痤疮丙酸杆菌作为标志物组合用于(a)皮肤分型;和/或(b)判断皮肤状态,如含水量、皮肤弹性,和/或老化程度,具有高灵敏性、高特异性的优点,具有重要的应用价值。(1) The present invention uses Moraxella oslo and Propionibacterium acnes as markers in combination for (a) skin typing; and/or (b) judging skin condition, such as moisture content, skin elasticity, and/or aging degree , has the advantages of high sensitivity and high specificity, and has important application value.
(2)本发明首次在亚洲人群发现奥斯陆莫拉菌和痤疮丙酸杆菌可作为标志物组合用于(a)将皮肤分型为M-Cutotype型、混合型和/或C-Cutotype型;和/或(b)判断皮肤状态。and /or (b) determine skin condition.
(3)本发明首次发现了一种不同于以往以宿主生理驱动作为分类依据(油性皮肤、干性皮肤、湿性皮肤)的新分类方式,新的分类方式以皮肤微生物作为分类依据,鉴定出了三种具有不同特征的皮肤型。而对这3种皮肤型进行分析,结果提示我们宿主生理所造成的营养差异可能是产生不同皮肤型的驱动因素。而且不同皮肤型所具有的微生物组群落可能会通过发挥特定的功能反作用于宿主皮肤,对皮肤健康和皮肤外观产生一定的影响。因此,对皮肤型的进一步研究可能有助于个性化医疗的发展,以更好地维持皮肤健康。(3) The present invention discovers for the first time a new classification method that is different from the previous classification based on the host physiological drive (oily skin, dry skin, wet skin). The new classification method uses skin microorganisms as the classification basis. Three skin types with different characteristics. The analysis of these three skin types suggests that nutritional differences caused by our host physiology may be the driving factors for the different skin types. Moreover, the microbiome communities of different skin types may react against the host skin by exerting specific functions, which may have certain effects on skin health and skin appearance. Therefore, further research on skin type may contribute to the development of personalized medicine to better maintain skin health.
(4)本发明首次发现M菌与皮肤表型的相关性,与年龄正相关,并且与一些皮肤衰老表型相关,如随着M菌的水平升高,皮肤油脂下降,含水量下降,光泽度下降,黄值(皮肤暗沉)升高;与痤疮的一些典型特征相关,如随着M菌增加,油脂下降,卟啉(多为C菌代谢产物,可促炎)下降,毛孔面积下降。(4) The present invention finds for the first time the correlation between M bacteria and skin phenotype, which is positively correlated with age, and is related to some skin aging phenotypes, such as with the increase of the level of M bacteria, the skin oil decreases, the moisture content decreases, and the luster decreases. It is associated with some typical features of acne, such as increased M bacteria, decreased oil, decreased porphyrins (mostly metabolites of C bacteria, which can be pro-inflammatory), and decreased pore area .
(5)本发明首次发现,提高痤疮丙酸杆菌相对水平(如含量),M型皮肤可向C型皮肤调整,可用于皮肤抗衰老。(5) The present invention finds for the first time that by increasing the relative level (eg content) of P. acnes, M-type skin can be adjusted to C-type skin, which can be used for skin anti-aging.
(6)本发明首次发现,提高奥斯陆莫拉菌相对水平(如含量),C型皮肤可向M型皮肤调整,用于治疗痤疮。(6) The present invention finds for the first time that by increasing the relative level (such as content) of Moraxella oslo, the C-type skin can be adjusted to the M-type skin, which is used for the treatment of acne.
(7)本发明首次发现,将单菌与皮肤表型做相关性分析,探究皮肤微生物是否可能导致宿主皮肤表型的变化,提供微生物与宿主之间相互作用研究的新见解和新角度。(7) The present invention finds for the first time that the correlation analysis between single bacteria and skin phenotypes is carried out to explore whether skin microorganisms may cause changes in the skin phenotype of the host, and to provide new insights and new perspectives for the study of the interaction between microorganisms and the host.
(8)本发明首次发现,利用细菌上清液处理宿主表皮细胞,在分子水平探究细菌与宿主之间的相互作用关系,而不只局限于相关性研究。(8) The present invention finds for the first time that the bacterial supernatant is used to treat the host epidermal cells to explore the interaction relationship between the bacteria and the host at the molecular level, and is not limited to correlation research.
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。下列实施例中未注明具体条件的实验方法,通常按照常规条件,或按照制造厂商所建议的条件。除非另外说明,否则百分比和份数按重量计算。The present invention will be further described below in conjunction with specific embodiments. It should be understood that these examples are only used to illustrate the present invention and not to limit the scope of the present invention. In the following examples, the experimental methods without specific conditions are usually in accordance with conventional conditions, or in accordance with the conditions suggested by the manufacturer. Percentages and parts are by weight unless otherwise indicated.
如无特别说明,本发明实施例中所用的试剂和材料均为市售产品。Unless otherwise specified, the reagents and materials used in the examples of the present invention are all commercially available products.
通用方法general approach
1.相关性分析:1. Correlation analysis:
1) 皮肤微生物样本采集与宏基因组测序 1) Skin microbial sample collection and metagenomic sequencing
招募上海常住人口作为本研究的志愿者。所有参与本研究的志愿者者会接受上海市皮肤病医院皮肤科医师的检查,以排除受试部位有皮炎湿疹、痤疮、银屑病、感染等皮肤病变,确保在过去6个月内没有任何皮肤疾病,同时排除过去6个月内使用全身或局部的抗生素治疗的志愿者。最后纳入294名的20岁-65岁的健康受试者,其中男性(M)46名,女性(F)248名(表1)。The Shanghai resident population was recruited as volunteers for this study. All volunteers participating in this study will be examined by a dermatologist at Shanghai Dermatology Hospital to rule out skin lesions such as dermatitis, eczema, acne, psoriasis, infection, etc. Skin disease, while excluding volunteers treated with systemic or topical antibiotics within the past 6 months. Finally, 294 healthy subjects aged 20-65 were included, including 46 males (M) and 248 females (F) (Table 1).
表1受试者人口统计学数据Table 1 Subject demographic data
Figure PCTCN2021135870-appb-000001
Figure PCTCN2021135870-appb-000001
受试者在采样当天仅使用清水洗脸,且在采样前一天避免使用任何护肤品或化妆品。采样地点保持室内温度为20摄氏度,湿度为50%。实验人员用蘸有0.15M NaCl和0.1%Tween20溶液的专用无菌拭子反复擦拭受试者额头 (Fh)、面颊(Ch)和鼻旁(Ns)三个部位约4cm2的区域,来回20次。然后将拭子折断,置于1.5ml无菌EP管中,于-80℃下冻存留待对其进行皮肤微生物基因组DNA的提取,采样部分示意图如图1所示。Subjects only washed their faces with water on the day of sampling, and avoided using any skin care products or cosmetics the day before sampling. The sampling site was maintained at an indoor temperature of 20 degrees Celsius and a humidity of 50%. The experimenter used a special sterile swab dipped in 0.15M NaCl and 0.1% Tween20 solution to repeatedly wipe the subject's forehead (Fh), cheeks (Ch) and paranasal (Ns) three parts about 4cm2 area, back and forth 20 times . Then, the swab was broken, placed in a 1.5ml sterile EP tube, and frozen at -80°C until the skin microorganism genomic DNA was extracted. The schematic diagram of the sampling part is shown in Figure 1.
通过全基因组扩增法对样本进行扩增,然后进行宏基因组测序,最终获得了822个面部皮肤微生物样本测序数据。通过SOAP2(版本2.21)计算每个基因的相对丰度,再根据每个基因的比对结果,计算来自同一菌种的基因相对丰度之和,该值代表该菌种的相对丰度。The samples were amplified by the whole genome amplification method, followed by metagenomic sequencing, and finally the sequencing data of 822 facial skin microbial samples were obtained. The relative abundance of each gene was calculated by SOAP2 (version 2.21), and then the sum of the relative abundances of genes from the same strain was calculated according to the alignment result of each gene, which represented the relative abundance of the strain.
2) 皮肤表型测量 2) Skin phenotypic measurements
对294名汉族受试者进行的所有表型测量均在温度为20摄氏度,湿度为50%的室内环境中进行。进行测试前,待测者静坐休息30分钟以上,确保其血液循环在可能的体力活动后能恢复到正常水平。表型测量的区域与微生物采集部位一致。分别用下述仪器(表2)对皮肤皮脂含量(sebum)、角质层含水量(hydration)、经表皮失水率(TEWL)、皮肤pH值、卟啉(porphyrin)、肤色(L*a*b)、色斑(lentigines)、毛孔(pores_area)、血管扩张(telangiectasia)、皱纹(elasticity)等表型进行测量。All phenotypic measurements on 294 Han subjects were performed in an indoor environment with a temperature of 20 degrees Celsius and a humidity of 50%. Before taking the test, the test subject sits and rests for more than 30 minutes to ensure that his blood circulation can return to normal levels after possible physical activity. The area where the phenotype was measured coincided with the microbial collection site. The following instruments (Table 2) were used to measure skin sebum content (sebum), stratum corneum water content (hydration), transepidermal water loss (TEWL), skin pH, porphyrin, skin color (L*a*) b) Phenotypes such as lentigines, pores_area, telangiectasia, and elasticity were measured.
表2表型测量仪器Table 2 Phenotypic Measurement Instruments
Figure PCTCN2021135870-appb-000002
Figure PCTCN2021135870-appb-000002
3)细菌丰度与皮肤表型相关性分析3) Correlation analysis between bacterial abundance and skin phenotype
基于R软件的psych包(版本2.0.12)对各种菌群在294名中国汉族人群面部分布的物种水平和皮脂含量、角质层含水量、经表皮失水率、皮肤pH值、色斑、卟啉、肤色、毛孔等表型进行相关性分析(Spearman Rank方法),以评估菌株水平和表型的相关性;并对相关性分析结果的P值进行FDR检验,校正后P值<0.05表示差异具有统计学意义。用R包pheatmap(版本1.0.12)绘制相关性热图作为结果展示。蓝色,负相关;红色:正相关;斯皮 尔曼相关性的显著水平:*,p<0.05;**,p<0.01;***,p<0.001。Based on the R software psych package (version 2.0.12), the species level and sebum content, stratum corneum water content, transepidermal water loss rate, skin pH value, pigmentation, Porphyrin, skin color, pores and other phenotypes were subjected to correlation analysis (Spearman Rank method) to evaluate the correlation between strain levels and phenotypes; FDR test was performed on the P value of the correlation analysis results, and the corrected P value <0.05 indicated The difference is statistically significant. Correlation heatmaps were drawn using the R package pheatmap (version 1.0.12) as the results. Blue, negative correlation; red: positive correlation; significant level of Spearman correlation: *, p<0.05; **, p<0.01; ***, p<0.001.
2.基质金属蛋白酶(MMP)表达实验:2. Matrix metalloproteinase (MMP) expression experiment:
1) 菌株上清液的准备 1) Preparation of strain supernatant
i.挑取自皮肤获得的冻存菌液,采用三区划线法分别划板至对应培养皿进行培养。待平板上生长出单菌落,挑取单菌落分别至对应培养基进行液体培养;i. Pick the frozen bacterial solution obtained from the skin, and use the three-zone streak method to plate to the corresponding petri dish for cultivation. When a single colony grows on the plate, pick a single colony to the corresponding medium for liquid culture;
ii.培养24h后,对细菌培养液抽提基因组DNA,并进行16S rDNA检测,确认三株细菌培养液依旧为目标菌株,无染菌情况存在;ii. After culturing for 24 hours, extract genomic DNA from the bacterial culture solution, and perform 16S rDNA detection to confirm that the three bacterial culture solutions are still the target strains, and no contamination exists;
iii.将已确认的菌进行液体培养,并分别设置无细菌接种的纯培养基为对照组;iii. The confirmed bacteria are cultured in liquid, and the pure medium without bacteria inoculation is set as the control group;
iv.将培养后的菌液用酶标仪检测600nm处的吸光值约为0.8;iv. Use a microplate reader to detect the absorbance at 600 nm of the cultured bacterial liquid at about 0.8;
v.将三株细菌菌液用0.22μm滤器过滤两次,除去细菌菌体,保留细菌上清液。纯培养基对照组进行同样操作;v. Filter the three bacterial strains twice with a 0.22 μm filter to remove the bacterial cells and retain the bacterial supernatant. The same operation was performed on the pure medium control group;
vi.将所得过滤细菌上清液和纯培养基上清液放入-80℃内储存,待用。vi. The obtained filtered bacterial supernatant and pure medium supernatant were stored at -80°C until use.
2) 细菌上清液孵育HaCaT细胞 2) Incubation of HaCaT cells with bacterial supernatant
i.培养人角质细胞(HaCaT细胞)1×10 6个。设置菌液上清处理组(实验组)和纯培养基对照组,每组三个重复。轻轻晃动培养板,使细胞分布均匀,放入37℃、5%CO 2细胞培养箱培养。表3为本发明使用的三种细菌; i. Culture human keratinocytes (HaCaT cells) 1×10 6 . The bacterial liquid supernatant treatment group (experimental group) and the pure medium control group were set, and each group was repeated three times. Gently shake the culture plate to distribute the cells evenly, and place it into a 37°C, 5% CO 2 cell incubator for culture. Table 3 is three kinds of bacteria used in the present invention;
ii.继续于培养箱内孵育24h,弃去细胞培养液,加入PBS轻微冲洗。而后每皿加入胰酶,放入细胞培养箱消化5min后离心800×g,5min,收集细胞。ii. Continue to incubate in the incubator for 24 hours, discard the cell culture medium, and add PBS to rinse slightly. Then, trypsin was added to each dish, placed in a cell incubator for digestion for 5 min, centrifuged at 800 × g for 5 min, and the cells were collected.
表3细菌培养基列表Table 3 List of bacterial culture media
Figure PCTCN2021135870-appb-000003
Figure PCTCN2021135870-appb-000003
Figure PCTCN2021135870-appb-000004
Figure PCTCN2021135870-appb-000004
3) 抽提细胞RNA 3) Extract cellular RNA
i.将收集的HaCaT细胞或原代成纤维细胞加入Trizol试剂,室温放置10min;i. Add the collected HaCaT cells or primary fibroblasts to Trizol reagent and place at room temperature for 10 minutes;
ii.向离心管内加入三氯甲烷,振荡混匀后,静置5min;ii. Add chloroform into the centrifuge tube, shake and mix, and let stand for 5 minutes;
iii.13200rpm,4℃,离心10min,吸取上层水相(约200μL)于另一mL离心管内;iii. 13200rpm, 4°C, centrifuge for 10min, suck the upper aqueous phase (about 200μL) into another mL centrifuge tube;
iv.加入等体积的异丙醇,上下颠倒混匀,室温静置5min;iv. Add an equal volume of isopropanol, invert up and down to mix, and let stand for 5 minutes at room temperature;
v.13200rpm,4℃,离心10min,弃上清,可观察到管底有白色沉淀;v. 13200rpm, 4℃, centrifuge for 10min, discard the supernatant, white precipitate can be observed at the bottom of the tube;
vi.加入75%乙醇(无水乙醇与DEPC水配制,现配现用,且用前需放置于-20℃冷却),轻轻振荡,使管底RNA沉淀悬浮;vi. Add 75% ethanol (prepared with absolute ethanol and DEPC water, ready to use, and should be placed at -20°C to cool before use), shake gently to suspend the RNA precipitation at the bottom of the tube;
vii.13200rpm,4℃,离心10min,弃上清;重复以上两步;vii.13200rpm, 4℃, centrifuge for 10min, discard the supernatant; repeat the above two steps;
viii.空离2min,并用移液器尽可能吸尽残留的乙醇,打开离心管盖,室温晾干5min;viii. Evacuate for 2 minutes, and use a pipette to absorb the residual ethanol as much as possible, open the lid of the centrifuge tube, and dry at room temperature for 5 minutes;
ix.加入DEPC水溶解RNA后,使用NanoDrop测定RNA的纯度和浓度,每个样本RNA浓度调平为200ng/μL。ix. After adding DEPC water to dissolve the RNA, use NanoDrop to determine the purity and concentration of RNA, and the RNA concentration of each sample is adjusted to 200ng/μL.
4) cDNA合成 4) cDNA synthesis
i.本实验使用Vazyme公司的HiScript III RT SuperMix for qPCR(+gDNA wiper)试剂盒进行反转录PCR合成cDNA。i. In this experiment, the HiScript III RT SuperMix for qPCR (+gDNA wiper) kit of Vazyme Company was used for reverse transcription PCR to synthesize cDNA.
ii.取共1μg总RNA进行反转录反应,剩余RNA于-80℃保存;ii. Take a total of 1 μg of total RNA for reverse transcription reaction, and store the remaining RNA at -80°C;
iii.进行反转录前,首先将去除RNA样本中可能混杂的基因组DNA。在RNase-free八连排管内中配制基因组DNA去除反应混合液(RNA sample:4×gDNA wiper Mix:RNase-free ddH 2O=5:4:7),用移液器轻轻吹打混匀后,再加入体积比0.25倍的5×HiScript qRT Super Mix混合。 iii. Prior to reverse transcription, possible confounding genomic DNA in the RNA sample will be removed first. The genomic DNA removal reaction mixture (RNA sample: 4×gDNA wiper Mix: RNase-free ddH 2 O = 5:4:7) was prepared in an RNase-free eight-row tube, and mixed with a pipette. , and then add 5×HiScript qRT Super Mix with a volume ratio of 0.25 to mix.
iv.将前述产物置于PCR仪内,37℃,15min;85℃,5s。反转录过程完成,将产物立即用于qPCR反应,或在-20℃保存。iv. Place the aforementioned product in a PCR machine, 37°C, 15min; 85°C, 5s. When the reverse transcription process is complete, the product is used immediately in the qPCR reaction, or stored at -20°C.
5) 实时定量PCR(Real-time PCR) 5) Real-time quantitative PCR (Real-time PCR)
i.本实验使用QIAGEN公司的QuantiFast SYBR Green PCR Kit进行实 时定量PCR(Real-time PCR),检测基因的相对表达水平。i. In this experiment, the QuantiFast SYBR Green PCR Kit of QIAGEN company was used for real-time quantitative PCR (Real-time PCR) to detect the relative expression level of the gene.
ii.将下表4中引物用DEPC水配制成2μM,混匀,待用;ii. Prepare the primers in Table 4 below with DEPC water to 2 μM, mix well, and set aside;
表4人引物序列Table 4 Human primer sequences
Figure PCTCN2021135870-appb-000005
Figure PCTCN2021135870-appb-000005
iii.在384孔板内配制Real-time PCR反应体系,Primers(2μM):cDNA:SYBR Master Mix(2×)=1:4:5;iii. Prepare a Real-time PCR reaction system in a 384-well plate, Primers (2 μM): cDNA: SYBR Master Mix (2×)=1:4:5;
iv.将384孔板置于离心机内,4℃,3000rpm,离心3min。将384孔板置于QuantStudioTM 7 Flex Real-Time PCR System内进行RT-PCR反应,反应程序如下表5;iv. Place the 384-well plate in a centrifuge, 4°C, 3000 rpm, and centrifuge for 3 minutes. The 384-well plate was placed in the QuantStudioTM 7 Flex Real-Time PCR System for RT-PCR reaction, and the reaction program was as follows in Table 5;
表5 Real-time PCR程序Table 5 Real-time PCR program
Figure PCTCN2021135870-appb-000006
Figure PCTCN2021135870-appb-000006
v.使用QuantStudioTM Real-Time PCR Software对实验结果进行统计处理,进一步按照2- △△T方法计算每个样本中基因的相对表达量,最终在GraphPad Prism 5.0软件中,采用T-test检验方法对实验结果进行分析并作图。显著性水平:*,p<0.05;**,p<0.01;***,p<0.001。 v. Use QuantStudioTM Real-Time PCR Software to perform statistical processing on the experimental results, and further calculate the relative expression of genes in each sample according to the 2- △△T method. Finally, in the GraphPad Prism 5.0 software, the T-test test method is used to detect The experimental results were analyzed and plotted. Significance level: *, p<0.05; **, p<0.01; ***, p<0.001.
实施例1汉族人群面部皮肤微生物组的组成Example 1 Composition of the facial skin microbiome of the Han population
研究对象:本研究经复旦大学生命科学学院伦理委员会批准,招募294名上海常住健康受试者作为本研究的志愿者。其中男性(M)46名,女性(F)248名。采集头面部额头(Fh)、面颊(Ch)和鼻旁(Ns)三个部位的皮肤微生物(请参考图1)。Subjects: This study was approved by the Ethics Committee of the School of Life Sciences, Fudan University, and 294 Shanghai resident healthy subjects were recruited as volunteers for this study. Among them, 46 were male (M) and 248 were female (F). The skin microbes were collected from three parts of the head, forehead (Fh), cheeks (Ch), and paranasal (Ns) (please refer to Figure 1).
通过宏基因组测序手段,结合生物信息分析,系统地描述了中国汉族人群健康皮肤微生物组的组成和功能特征。通过与人类微生物组计划(HMP)的美国人皮肤微生物样本数据相比对,我们发现中国人群中存在一种相对水平显著高于美国人的细菌——奥斯陆莫拉(M.osloensis),奥斯陆莫拉菌在-新加坡华人中均相对水平较高,此菌种可能是东亚人群皮肤菌群的特征菌株之一(请参考图2)。Through metagenomic sequencing, combined with bioinformatics analysis, the composition and functional characteristics of the healthy skin microbiome of the Chinese Han population were systematically described. By comparing with the American skin microbiome sample data from the Human Microbiome Project (HMP), we found that there is a bacterium with a significantly higher relative level in the Chinese population than Americans - M. osloensis, Oslo Mora The level of La. spp. was relatively high among Chinese Singaporeans, and this strain may be one of the characteristic strains of the skin flora of East Asian populations (please refer to Figure 2).
实施例2基于皮肤微生物组的群体分型分析Example 2 Population typing analysis based on skin microbiome
皮肤微生物组与肠道微生物组一样,会受到多种因素的影响,且存在显著的个体差异性。在研究中,本发明借鉴肠型的方法,基于皮肤微生物对人群进行分型并探究产生分型的驱动因素,以寻找皮肤微生物组背后的潜在规律,并为临床诊断提供新划分标准。The skin microbiome, like the gut microbiome, is affected by a variety of factors, and there are significant individual differences. In the research, the present invention draws on the method of enterotype to classify the population based on skin microbes and explore the driving factors of the type, so as to find the potential rules behind the skin microbiome, and provide a new classification standard for clinical diagnosis.
本发明筛选了三个部位皮肤微生物组数据没有缺失的受试者,总计为247人。The present invention screened subjects with no missing skin microbiome data in three sites, a total of 247 subjects.
基于皮肤微生物组的数据,对这247个受试者进行皮肤型的鉴定。首先,使用PAM方法分别对三个部位的样本进行聚类,并用CH指数确定最佳的簇数。请参考图3,CH指数的结果显示,当簇数为2时CH指数的得分最高,因此三个部位中最佳簇数都为2类。Skin type identification was performed on these 247 subjects based on skin microbiome data. First, the samples from the three parts were clustered using the PAM method, and the CH index was used to determine the optimal number of clusters. Please refer to Figure 3, the results of the CH index show that when the number of clusters is 2, the CH index has the highest score, so the optimal number of clusters in the three parts is 2.
基于该结果,本发明对样本进行分型分析,分为2类,并分别使用JSD距离和Bray-Curtis距离对三个部位的样本的分型结果进行PCoA分析。请参考图4A~L,结果显示,三个部位的样本分型结果均能被有效分为2类,且对该分类贡献度最大的微生物分别为痤疮丙酸杆菌、奥斯陆莫拉菌,即一类富集痤疮丙酸杆菌,另一类富集奥斯陆莫拉菌。根据这一结果,我们将两种皮肤型(cutotype)分别命名为C-Cutotype和M-Cutotype。Based on the result, the present invention performs genotyping analysis on the samples, which are divided into two categories, and respectively use the JSD distance and the Bray-Curtis distance to perform PCoA analysis on the genotyping results of the samples in the three parts. Please refer to Figures 4A-L. The results show that the sample typing results of the three parts can be effectively divided into two categories, and the microorganisms that contribute the most to the classification are Propionibacterium acnes and Moraxella oslo, namely a The class enriches P. acnes and the other class enriches Moraxella oslo. Based on this result, we named the two cutotypes as C-Cutotype and M-Cutotype, respectively.
本发明基于额头的皮肤微生物组数据分析了C-Cutotype和M-Cutotype的差异菌群。请参考图5,颜色代表微生物的相对水平(比如,相对丰度),每 一列为一个样本,每一行为一种微生物。差异分析的结果显示,可能由于菌群之间的相互影响,某些微生物更偏好于某一种皮肤型。比如,C-Cutotype中富集贪婪丙酸杆菌、颗粒丙酸杆菌、葡萄球菌属、痤疮丙酸噬菌体和葡萄球菌噬菌体。而M-Cutotype中则富集牛眼莫拉氏菌(Moraxella bovoculi)和冷杆菌属(Psychrobacter sp.)。The present invention analyzes the differential flora of C-Cutotype and M-Cutotype based on the skin microbiome data of the forehead. Referring to Figure 5, the colors represent relative levels (eg, relative abundance) of microorganisms, with one sample per column and one microorganism per row. The results of the differential analysis showed that some microbes prefer a certain skin type, possibly due to the interaction between the flora. For example, P. greedy, P. granulosum, staphylococcus, P. acnes and staphylococcus phage were enriched in C-Cutotype. In M-Cutotype, Moraxella bovoculi and Psychrobacter sp. were enriched.
本发明基于差异菌群的相对水平进行了相关性分析,并用网络图的形式进行展现。请参考图6,结果显示,在同一种皮肤型中富集的微生物之间存在强烈的正相关,而富集于不同皮肤型之间的微生物之间存在强烈的负相关。这一分析结果说明,富集于同一种皮肤型的微生物可能分别占据不同的生态位,彼此之间形成了稳定的生态网络,构建了一个强有力的微生物群落,以抵御其他微生物包括机会性和潜在病原性微生物的新定植。In the present invention, correlation analysis is performed based on the relative levels of the differential flora, and is displayed in the form of a network diagram. Referring to Figure 6, the results show that there is a strong positive correlation between microorganisms enriched in the same skin type, while a strong negative correlation exists between microorganisms enriched between different skin types. The results of this analysis indicate that microorganisms enriched in the same skin type may occupy different ecological niches, form a stable ecological network with each other, and build a strong microbial community to resist other microorganisms including opportunistic and New colonization of potentially pathogenic microorganisms.
基于此247人,共计741样本,我们给出皮肤型的分型依据M菌与C菌水平(如含量)的比值(M/C)如表6所示。Based on this 247 people, a total of 741 samples, we give the skin type based on the ratio of M bacteria to C bacteria levels (such as content) (M/C) as shown in Table 6.
表6Table 6
   C型Type C 混合型Hybrid M型M type
面颊cheek ≤0.75≤0.75 0.75<M/C<1.680.75<M/C<1.68 ≥1.68≥1.68
额头forehead ≤1.24≤1.24 1.24<M/C<2.181.24<M/C<2.18 ≥2.18≥2.18
鼻翼Nose ≤0.34≤0.34 0.34<M/C<0.550.34<M/C<0.55 ≥0.55≥0.55
基于微生物的来源部位不同,具体分型的参考值不同,临床应用时的皮肤分型采样原则:亟待改善的面部皮肤部位,再参照以上数据分型。Based on the different source parts of microorganisms, the reference values for specific classification are different. The skin classification sampling principle in clinical application: the facial skin parts that need to be improved, and then refer to the above data classification.
此外,C菌全名痤疮丙酸杆菌,其水平(如丰度)与皮肤痤疮关系紧密。M菌的相关报道极少,本发明的研究首次发现M菌与皮肤表型的相关性,与年龄正相关,并且与一些皮肤衰老表型相关。In addition, the full name of C bacteria is Propionibacterium acnes, and its level (eg abundance) is closely related to skin acne. There are very few related reports on M bacteria. The present study finds for the first time that M bacteria are correlated with skin phenotypes, are positively correlated with age, and are associated with some skin aging phenotypes.
发明人进行了受试者肤质与M/C变化实验,得到表2结果,显示M/C比与肤质有关。随着M菌的水平升高,皮肤油脂下降,含水量下降,光泽度下降,黄值(皮肤暗沉)升高;与痤疮的一些典型特征相关,如随着M菌增加,油脂下降,卟啉(多为C菌代谢产物,可促炎)下降,毛孔面积下降。The inventors conducted experiments on changes in skin texture and M/C of subjects, and obtained the results in Table 2, which showed that the M/C ratio was related to skin texture. As the level of M bacteria increased, skin oil decreased, moisture content decreased, gloss decreased, and yellow value (skin dullness) increased; associated with some typical features of acne, such as increased M bacteria, decreased oil, porphyrin Morphine (mostly C bacteria metabolites, which can promote inflammation) decreased, and the pore area decreased.
表7列举了相关表型与M/C值得相关性,所列表型均为显著相关(p<0.05)。Table 7 lists the correlation between related phenotypes and M/C value, and all phenotypes are significantly correlated (p<0.05).
表7Table 7
位置Location 变量1variable 1 变量2variable 2 相关系数Correlation coefficient P值P value
Fh额头Fh forehead 卟啉Porphyrin M/C ratioM/C ratio -0.4788-0.4788 2.30E-162.30E-16
   油脂grease M/C ratioM/C ratio -0.2592-0.2592 2.24E-052.24E-05
    含水量water content M/C ratioM/C ratio -0.1782-0.1782 3.87E-033.87E-03
   光泽度Gloss M/C ratioM/C ratio -0.1585-0.1585 1.03E-021.03E-02
   毛孔面积Pore area M/C ratioM/C ratio -0.1405-0.1405 2.32E-022.32E-02
              
Ck面颊Ck cheeks 卟啉Porphyrin M/C ratioM/C ratio -0.4103-0.4103 1.65E-121.65E-12
   含水量water content M/C ratioM/C ratio -0.2876-0.2876 1.35E-061.35E-06
   油脂grease M/C ratioM/C ratio -0.2217-0.2217 2.22E-042.22E-04
              
Ns鼻旁Ns beside the nose 卟啉Porphyrin M/C ratioM/C ratio -0.3722-0.3722 1.35E-101.35E-10
   皮肤黄值skin yellowness M/C ratioM/C ratio 0.19930.1993 8.16E-048.16E-04
   毛孔大小Pore size M/C ratioM/C ratio -0.1383-0.1383 2.09E-022.09E-02
   毛孔面积Pore area M/C ratioM/C ratio -0.1320-0.1320 2.75E-022.75E-02
   油脂grease M/C ratioM/C ratio 鼻旁未测Nasal not tested   
   含水量water content M/C ratioM/C ratio 鼻旁未测Nasal not tested   
实施例3微生物皮肤型的生物学意义Example 3 Biological significance of microbial skin type
基于基因水平(如丰度)谱,对样本进行了PCoA分析,结果显示两种皮肤型能够有效分开,说明在功能上两种皮肤型存在显著差异。具体地,C-Cutotype的基因富集于碳水化合物和甾醇的代谢和脂肪酸的合成,而M-Cutotype中微生物组的基因更多与氨基酸、芳香族化合物和一些脂类的合成如肌醇等相关。过去的研究报道痤疮丙酸杆菌可利用碳水化合物作为碳源,基因功能富集的结果亦发现C-Cutotype中有17个KEGG功能模块都与磷酸转移酶系统(PTS)有关。在原核生物中,该系统已知负责碳水化合物转运和磷酸化,与葡萄糖、麦芽糖、乳糖、果糖和纤维二糖的代谢能力有关,这可能反映出了C-Cutotype依赖于碳水化合物作为营养来源。反之,之前对奥斯陆莫拉菌的研究发现,该微生物无法利用任何碳水化合物,依赖脂肪酸和醇类作为碳源。这进一步说明可能两种皮肤型构成了两种营养需求不同的群落。Based on gene-level (eg, abundance) profiles, PCoA analysis of the samples showed that the two skin types could be effectively separated, indicating that there are significant differences in function between the two skin types. Specifically, the genes of C-Cutotype are enriched in the metabolism of carbohydrates and sterols and the synthesis of fatty acids, while the genes of the microbiome in M-Cutotype are more related to the synthesis of amino acids, aromatic compounds and some lipids such as inositol, etc. . Previous studies reported that P. acnes could utilize carbohydrates as a carbon source, and the results of gene function enrichment also found that 17 KEGG functional modules in C-Cutotype were all related to the phosphotransferase system (PTS). In prokaryotes, this system is known to be responsible for carbohydrate transport and phosphorylation and is associated with the ability to metabolize glucose, maltose, lactose, fructose and cellobiose, possibly reflecting C-Cutotype's dependence on carbohydrates as a nutrient source. Conversely, previous research on Moraxella oslo found that the microbe was unable to utilize any carbohydrates and relied on fatty acids and alcohols as carbon sources. This further suggests that the two skin types may constitute two communities with different nutritional requirements.
由于皮肤微环境是皮肤微生物的生长环境,决定了微生物可获取的营养物质。因此,为了探究皮肤表型是否是导致不同皮肤型的驱动因素,我们进一步分析了两种皮肤型的表型差异。请参考图7,结果发现,两种皮肤型在角质层水分、油脂、皮肤肤色上具有显著差异。相比之下,C-Cutotype的油脂、含水量更高,而M-Cutotype的皮肤则更加干燥。由于油脂是微生物的主要营养来源,因此该结果进一步提示我们营养需求的差异是导致不同皮肤型的驱动因 素。Since the skin microenvironment is the growth environment of skin microorganisms, it determines the nutrients available to the microorganisms. Therefore, to explore whether the skin phenotype is the driving factor for the different skin types, we further analyzed the phenotypic differences between the two skin types. Referring to Figure 7, it was found that the two skin types had significant differences in stratum corneum moisture, oil, and skin color. In contrast, C-Cutotype has higher oil and moisture content, while M-Cutotype has drier skin. Since oil is the main source of nutrients for microbes, this result further suggests that differences in our nutritional requirements are the driving factors for different skin types.
此外,M-Cutotype的皮肤表型特点与老年人的皮肤特点相似,因此,我们比较了两种皮肤型的年龄是否存在差异。请参考图8,与预期一致,M-Cutotype组的年龄显著大于C-Cutotype,但是进一步分析发现,在不同年龄段中都存在C-Cutotype和M-Cutotype,也就是老年人中有C-Cutotype,年轻人中存在M-Cutotype。因此,我们猜测年龄不是真正的决定因素,营养需求是直接决定因素。而年龄的差异可能是由于衰老过程中宿主生理的变化影响了皮肤表型,从而导致M-Cutotype的年龄更大。In addition, the skin phenotypic characteristics of M-Cutotype were similar to those of the elderly, therefore, we compared whether there were differences in age between the two skin types. Please refer to Figure 8. As expected, the age of the M-Cutotype group was significantly larger than that of the C-Cutotype group, but further analysis found that both C-Cutotype and M-Cutotype existed in different age groups, that is, C-Cutotype in the elderly , M-Cutotype is present in young adults. Therefore, we guess that age is not the real determinant, and nutritional needs are the direct determinant. The difference in age may be due to changes in host physiology during aging that affect the skin phenotype, resulting in an older M-Cutotype.
实施例4奥斯陆莫拉菌与皮肤衰老表型的相关性Example 4 Correlation of Moraxella oslo with skin aging phenotype
本研究采集了248名上海常住健康女受试者的额头(Fh)、面颊(Ch)和鼻旁(Ns)三个部位的皮肤菌群,分析了奥斯陆莫拉菌与年龄以及皮肤表型进行相关性分析,通过计算Spearman系数并用FDR方法对P值进行校正,采用校正后P值小于0.05为筛选标准。请参考图9,结果发现,三个部位的奥斯陆莫拉菌水平均与年龄存在显著正相关,与卟啉存在显著负相关。此外,与面颊斑点呈正相关,与面颊角质层水分、油脂以及额头的油脂含量呈负相关性。此外,奥斯陆莫拉菌与其它衰老表型也存在弱正相关的趋势。In this study, the skin microbiota of three parts of the forehead (Fh), cheeks (Ch) and paranasal (Ns) of 248 healthy female subjects living in Shanghai were collected, and the correlation between Moraxella oslo and age and skin phenotype was analyzed. For correlation analysis, the Spearman coefficient was calculated and the P value was corrected by the FDR method. The corrected P value was less than 0.05 as the screening standard. Please refer to Figure 9. It was found that the levels of Moraxella oslo in the three parts were significantly positively correlated with age, and significantly negatively correlated with porphyrin. In addition, there was a positive correlation with cheek spots, and a negative correlation with moisture, oil in the stratum corneum of the cheeks, and oil content in the forehead. In addition, Moraxella oslo also showed a weak positive correlation trend with other aging phenotypes.
实施例5M菌皮肤衰老的潜在靶点Example 5 Potential targets for skin aging by M bacteria
在M-Cutotype中,我们观察到皮肤微生物组的异柠檬酸裂解酶(aceA)和苹果酸合成酶(aceB)基因富集。而这些基因的功能与乙醛酸循环有关,有研究证明了乙醛酸循环会参与乙氧基的分解代谢,这些结果为皮肤微生物参与辛基苯酚类聚氧乙烯醚(OPEs)降解提供了基础。而OPE降解形成的烷基酚和短聚氧基代谢物具有内分泌干扰活性。其中,烷基酚乙氧基化物(APE)具有类似雌激素活性,已有实验证明这类化合物在体内与体外均能模拟雌二醇的作用,被称为环境雌激素。因此,皮肤微生物有可能会干扰雌二醇的产生,而雌二醇对防治皮肤老化至关重要(请参考图10)。In M-Cutotype, we observed enrichment of isocitrate lyase (aceA) and malate synthase (aceB) genes in the skin microbiome. The functions of these genes are related to the glyoxylic acid cycle. Studies have shown that the glyoxylic acid cycle is involved in the catabolism of ethoxylates. These results provide a basis for skin microorganisms to participate in the degradation of octylphenol polyoxyethylene ethers (OPEs). . The alkylphenols and short polyoxy metabolites formed by the degradation of OPE have endocrine disrupting activity. Among them, alkylphenol ethoxylates (APE) have estrogen-like activities, and it has been proved that these compounds can mimic the effect of estradiol in vivo and in vitro, and are called environmental estrogens. Therefore, skin microbes have the potential to interfere with the production of estradiol, which is essential for preventing skin aging (see Figure 10).
1.请参考图11,基因功能差异分析的结果显示M-Cutotype富集于β-胡萝卜素合成的通路,该结果说明M-Cutotype可能会合成更多的β-胡萝卜素。而β-胡萝卜素与皮肤变黄有关。1. Please refer to Figure 11. The results of gene function difference analysis show that M-Cutotype is enriched in the pathway of β-carotene synthesis, which indicates that M-Cutotype may synthesize more β-carotene. Beta-carotene is associated with yellowing of the skin.
2.我们使用M菌的培养液刺激角质形成细胞,使用转录组学的方法探索 M菌的潜在致老化机制。2. We stimulated keratinocytes with the culture medium of M. spp. and explored the potential aging mechanism of M. spp. using transcriptomic methods.
RNA-Seq差异表达基因的信号通路富集分析提示奥斯陆莫拉菌可通过信号通路影响皮肤细胞,主要包括调控胶原的合成与分解。请参考图12,RNAseq结果提示差异基因大量富集于胶原代谢过程、细胞外基质分解等与老化表型强烈相关的生物学过程。Signal pathway enrichment analysis of differentially expressed genes by RNA-Seq suggested that Moraxella oslo could affect skin cells through signaling pathways, mainly including regulation of collagen synthesis and decomposition. Please refer to Figure 12. The RNAseq results indicated that the differential genes were abundantly enriched in biological processes such as collagen metabolism and extracellular matrix decomposition, which were strongly related to the aging phenotype.
实施例6调节奥斯陆莫拉菌水平的方法Example 6 Methods of Regulating Moraxella Oslo Levels
在前面的分析中,已知奥斯陆莫拉菌跟年龄、皮肤衰老表型有一定关联。本研究中利用单一的皮肤表面化合物孵育奥斯陆莫拉菌,通过检验活菌数量,从而反应出微生物对不同皮肤表面化合物的利用情况,以及特定化合物对奥斯陆莫拉菌的毒性。最终通过调节奥斯陆莫拉菌偏好化合物或毒性化合物的量,可以调控奥斯陆莫拉菌的生长,从而达到延缓衰老的目的。In the previous analysis, Moraxella oslo was known to be associated with age and skin aging phenotypes. In this study, a single skin surface compound was used to incubate Moraxella oslo, and the number of viable bacteria was examined to reflect the microbial utilization of different skin surface compounds and the toxicity of specific compounds to Moraxella oslo. Finally, by adjusting the amount of the preferred compounds or toxic compounds of Moraxella oslo, the growth of Moraxella oslo can be regulated, so as to achieve the purpose of delaying aging.
请参考图13,本研究中利用CCK-8和Dye mix A两种方法探究32种皮肤表面化合物对奥斯陆莫拉菌生长的影响。化合物分别为:L-赖氨酸、L-谷氨酰胺、L-组氨酸、L-精氨酸、牛胆酸、肌酸酐、D-葡萄糖、L-乳酸、甘油、2-羧基苯甲醛、尿素、SDS、L-苏氨酸、L-色氨酸、甘氨酸、L-蛋氨酸、L-丝氨酸、L-谷氨酸、L-苯丙氨酸、L-胱氨酸、L-酪氨酸、L-亮氨酸、L-异亮氨酸Please refer to Figure 13. In this study, CCK-8 and Dye mix A were used to explore the effects of 32 skin surface compounds on the growth of Moraxella oslo. The compounds are: L-lysine, L-glutamine, L-histidine, L-arginine, taurocholic acid, creatinine, D-glucose, L-lactic acid, glycerol, 2-carboxybenzaldehyde , urea, SDS, L-threonine, L-tryptophan, glycine, L-methionine, L-serine, L-glutamic acid, L-phenylalanine, L-cystine, L-tyrosine Acid, L-Leucine, L-Isoleucine
、L-鸟氨酸盐酸盐、L-瓜氨酸、L-脯氨酸、L-缬氨酸、L-丙氨酸、D-天冬氨酸、反式-4-羟基-L-脯氨酸、尿酸、牛磺酸。其中,L-谷氨酰胺、L-组氨酸、L-丝氨酸、L-脯氨酸对奥斯陆莫拉菌的生长具有显著促进作用,而SDS具有显著抑制作用。, L-ornithine hydrochloride, L-citrulline, L-proline, L-valine, L-alanine, D-aspartic acid, trans-4-hydroxy-L- Proline, uric acid, taurine. Among them, L-glutamine, L-histidine, L-serine, and L-proline significantly promoted the growth of Moraxella oslo, while SDS had a significant inhibitory effect.
实施例7其他国家人群检测Example 7 Population detection in other countries
为了验证所获得的皮肤型是否广泛存在,我们下载了多个公开数据,基于不同种族、不同部位、不同健康状况的皮肤微生物组数据对皮肤型的存在进行验证。In order to verify whether the obtained skin types are widespread, we downloaded multiple public data and verified the existence of skin types based on skin microbiome data of different races, different parts, and different health conditions.
首先我们使用了新加坡华人肘窝部位(湿润类型)的皮肤宏基因组数据,该数据中存在患有特异性皮炎(AD)的患者和健康人群。请参考图14结果发现,该数据的样本可以被有效分为2类,且与之前的结果相同,一类富集痤疮丙酸杆菌,另一类富集奥斯陆莫拉菌,该结果提示我们皮肤型的存在不受到皮肤健康状况和部位的影响。We first used skin metagenomic data from the cubital fossa site (wet type) in Singapore Chinese in patients with atopic dermatitis (AD) and healthy individuals. Please refer to Figure 14. It is found that the samples of this data can be effectively divided into two categories, which are the same as the previous results. One is enriched with P. acnes and the other is enriched with Moraxella oslo. This result suggests that our skin The presence of the type is not affected by skin health and location.
进一步,我们使用了菲律宾儿童(头皮和颈部)和意大利人银屑病的公开皮肤宏基因组数据,发现了一致的结果,请参考图15,分型结果显示人群能够被有效分为两类,一类为C-Cutotype,另一类为M-Cutotype。Further, we used publicly available skin metagenomic data of psoriasis in Filipino children (scalp and neck) and Italians and found consistent results, please refer to Figure 15. The typing results show that the population can be effectively divided into two categories, One is C-Cutotype and the other is M-Cutotype.
综上,本发明证明了皮肤型广泛存在,且不受到皮肤部位、种族、健康状况等影响。In conclusion, the present invention proves that skin types exist widely and are not affected by skin location, race, health status, and the like.
实施例8皮肤状态分型系统Example 8 Skin condition typing system
依据前述实施例我们研发了一种皮肤状态分型系统,所述系统包含特征接收模块、计算处理模块以及结果输出模块,各模块通过有线或无线方式连接,其分型步骤如下:According to the foregoing embodiment, we have developed a skin condition typing system, the system includes a feature receiving module, a calculation processing module and a result output module, each module is connected by wire or wireless, and the typing steps are as follows:
(a)采集受试者面部的皮肤微生物样本并进行检测,进一步产生皮肤样本特征数据。所述皮肤样本特征数据为奥斯陆莫拉菌和痤疮丙酸杆菌各自的水平。其中采集部位同实施例1所述,检测方法如检测方法所述。(a) Collect and detect skin microbe samples from the subject's face to further generate skin sample feature data. The skin sample characteristic data is the respective levels of Moraxella oslo and P. acnes. The collection site is the same as that described in Embodiment 1, and the detection method is as described in the detection method.
(b)将所述皮肤样本特征数据自所述特征接收模块输入该系统。(b) inputting the skin sample feature data into the system from the feature receiving module.
(c)所述处理模块接收来自特征接收模块的皮肤样本特征数据,计算定量出来的奥斯陆莫拉菌和痤疮丙酸杆菌各自的比例或彼此之间的相对比例,并且基于所获得的各自的比例或彼此之间的相对比例,与皮肤分型或特征表征的标准值进行比较,从而得出皮肤分型和/或皮肤状态的判断结果(c) the processing module receives the skin sample characteristic data from the characteristic receiving module, calculates the respective ratios of the quantified Moraxella oslo and P. acnes or the relative ratios between each other, and based on the obtained respective ratios or the relative proportions of each other, compared with the standard value of skin type or characteristic characterization, so as to obtain the judgment result of skin type and/or skin condition
(d)结果输出模块,所述输出模块可为任何终端,例如显示器、打印机、平板电脑(PAD)、智能手机等,用于接收并输出判断结果。(d) A result output module, the output module can be any terminal, such as a display, a printer, a tablet computer (PAD), a smart phone, etc., for receiving and outputting the judgment result.
所述系统包括一储存器,其中所述储存器中存储有标准值的阈值信息。The system includes a storage, wherein threshold information of standard values is stored in the storage.
所述皮肤分型和/或皮肤状态对应的标准值为:The standard values corresponding to the skin type and/or skin state are:
皮肤类型为C型(或I型):当所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≤1.3,较佳地,M/C≤0.8,更佳的M/C≤0.4。该表型的皮肤状态:油脂、含水量更高、皮肤弹性好。Skin type is C (or type I): when the ratio (M/C) of the level (eg content) (M) of the Moraxella oslo to the level (eg content) (C) of the P. acnes When the following conditions are met: M/C≤1.3, preferably, M/C≤0.8, more preferably M/C≤0.4. Skin state of this phenotype: oily, higher water content, good skin elasticity.
皮肤类型为M型(III型):当所述样品中的所述奥斯陆莫拉菌的水平(如含量)(M)与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:M/C≥0.5,较佳地,M/C≥1.8,更佳地,M/C≥2.2。该表型的皮肤状态:油脂、含水量较差,皮肤弹性差,皮肤衰老程度高。The skin type is M type (type III): when the ratio of the level (eg content) (M) of the Moraxella oslo to the level (eg content) (C) of the P. acnes in the sample ( M/C) meets the following conditions: M/C≥0.5, preferably, M/C≥1.8, more preferably, M/C≥2.2. The skin condition of this phenotype: poor oil and water content, poor skin elasticity, and high degree of skin aging.
皮肤类型为混合型(或II型):当所述奥斯陆莫拉菌的水平(如含量)(M) 与所述痤疮丙酸杆菌的水平(如含量)(C)的比例(M/C)符合以下条件时:0.3≤M/C≤2.5,较佳地,0.3≤M/C≤2.3,更佳地,0.8≤M/C≤1.8。该表型的皮肤状态介于C型与M型间。The skin type is mixed (or type II): when the ratio (M/C) of the level (eg content) (M) of the Moraxella oslo to the level (eg content) (C) of the P. acnes When the following conditions are met: 0.3≤M/C≤2.5, preferably, 0.3≤M/C≤2.3, more preferably, 0.8≤M/C≤1.8. The skin state of this phenotype is between C and M types.
实施例9细菌与皮肤表型做相关性分析Example 9 Correlation analysis between bacteria and skin phenotype
基于R软件对奥斯陆莫拉菌、痤疮丙酸杆菌和表皮葡萄球菌的物种水平和宿主面部3个部位(脸颊、额头和鼻旁)的皮脂含量、角质层含水量、经表皮失水率、皮肤pH值、色斑、卟啉、肤色、毛孔等宿主皮肤表型进行相关性分析,以评估菌株水平和表型的相关性。Species levels of Moraxella oslo, Propionibacterium acnes and Staphylococcus epidermidis based on R software and sebum content, stratum corneum water content, transepidermal water loss rate, skin Correlation analysis was performed on host skin phenotypes such as pH, pigmentation, porphyrin, skin color, pores, etc., to evaluate the correlation between strain levels and phenotypes.
结果显示,图16:三个部位的细菌丰度与表型之间的相关性结果具有一致性,即奥斯陆莫拉菌与年龄、肤色发黑发黄呈正相关,与皮肤含水量、皮脂以及卟啉含量呈负相关。痤疮丙酸杆与奥斯陆莫拉菌正好呈现相反趋势。表皮葡萄球菌与色斑呈负相关,与表皮含水量呈现正相关。以上提示,三种菌与皮肤的衰老有一定关联。The results show that Figure 16: The correlation between bacterial abundance and phenotype in the three parts is consistent, that is, Moraxella oslo is positively correlated with age, skin color black and yellow, and skin water content, sebum and porphyrin The content of morpholino was negatively correlated. Propionibacterium acnes and Moraxella oslo showed opposite trends. Staphylococcus epidermidis was negatively correlated with pigmentation and positively correlated with epidermal water content. The above suggests that the three kinds of bacteria are related to skin aging.
实施例10细菌上清液处理皮肤细胞的分子水平验证Example 10 Molecular-level verification of skin cells treated with bacterial supernatant
将奥斯陆莫拉菌、痤疮丙酸杆菌和表皮葡萄球菌的细菌上清液分别处理宿主表皮中含量最多的细胞——角质形成细胞(HaCaT细胞系),通过QPCR探究被孵育后的细胞表达谱的改变情况,主要关注与胶原降解和细胞外基质组装相关的基因—基质金属蛋白酶(MMPs)。特别的是,MMPs负责降解细胞外基质(ECM)蛋白,促进光老化。通过分子水平的验证,探究细菌与宿主皮肤表型的关联。The bacterial supernatants of Moraxella oslo, Propionibacterium acnes and Staphylococcus epidermidis were treated with the most abundant cells in the host epidermis-keratinocytes (HaCaT cell line), and the expression profiles of the incubated cells were explored by QPCR. The changes focused on genes involved in collagen degradation and extracellular matrix assembly—matrix metalloproteinases (MMPs). In particular, MMPs are responsible for degrading extracellular matrix (ECM) proteins and promoting photoaging. Through molecular-level verification, the association between bacteria and host skin phenotypes was explored.
QPCR结果显示,图17-19,经过奥斯陆莫拉菌菌液上清处理后的HaCaT细胞,其MMP1、MMP10、MMP12和MMP13的表达量相较于对照组显著升高,而痤疮丙酸杆菌和表皮葡萄球菌上清液处理HaCaT细胞后,MMPs表达量无显著性差异。表明,奥斯陆莫拉菌可促进宿主皮肤衰老,同时也说明,皮肤微生物促进皮肤衰老,并不是普遍效应,而是特定菌株具有的效应。The QPCR results show that, as shown in Figure 17-19, the expressions of MMP1, MMP10, MMP12 and MMP13 in HaCaT cells treated with Moraxella oslo supernatant were significantly higher than those in the control group, while P. acnes and There was no significant difference in the expression of MMPs in HaCaT cells treated with Staphylococcus epidermidis supernatant. It is shown that Moraxella oslo can promote host skin aging, and it also shows that skin microbes promote skin aging, not a general effect, but an effect of specific strains.
在本发明提及的所有文献都在本申请中引用作为参考,就如同每一篇文献被单独引用作为参考那样。此外应理解,在阅读了本发明的上述讲授内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申 请所附权利要求书所限定的范围。All documents mentioned herein are incorporated by reference in this application as if each document were individually incorporated by reference. In addition, it should be understood that after reading the above-mentioned teaching content of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of this application.

Claims (13)

  1. 一种奥斯陆莫拉菌或其检测试剂的用途,其特征在于,用于(a)皮肤分型;和/或(b)判断或表征皮肤状态;或用于制备一试剂或试剂盒,所述试剂或试剂盒用于(a)皮肤分型;和/或(b)判断或表征皮肤状态。A use of Moraxella oslo or a detection reagent thereof, characterized in that, for (a) skin typing; and/or (b) judging or characterizing skin condition; or for preparing a reagent or kit, the The reagents or kits are used to (a) type skin; and/or (b) determine or characterize skin conditions.
  2. 如权利要求1所述的用途,其特征在于,所述皮肤状态包括:皮肤年龄、皮肤含水量、皮肤弹性、皮肤颜色、皮肤衰老程度。The use of claim 1, wherein the skin condition comprises: skin age, skin moisture content, skin elasticity, skin color, and skin aging degree.
  3. 一种标志物组合,其特征在于,所述标志物组合包括奥斯陆莫拉菌和痤疮丙酸杆菌。A marker combination, characterized in that the marker combination comprises Moraxella oslo and Propionibacterium acnes.
  4. 如权利要求3所述的标志物组合,其特征在于,所述标志物组合还包含(a)牛眼莫拉氏菌(Moraxella bovoculi)和/或冷杆菌属(Psychrobacter sp.);和/或(b)贪婪丙酸杆菌(Propionibacterium avidum)、颗粒丙酸杆菌(Propionibacterium granulosum)、葡萄球菌属(Staphylococcus)、痤疮丙酸噬菌体和/或葡萄球菌噬菌体。The marker combination of claim 3, wherein the marker combination further comprises (a) Moraxella bovoculi and/or Psychrobacter sp.; and/or (b) Propionibacterium avidum, Propionibacterium granulosum, Staphylococcus, Propionibacterium acnes and/or Staphylococcus phage.
  5. 一种皮肤分型或判断皮肤状态的方法,其特征在于,所述方法包括:A method for skin typing or judging skin state, characterized in that the method comprises:
    (1)提供一来源于待测对象皮肤的样品,对样品标志物组合中各标志物的水平进行检测,所述组合包括以下标志物:奥斯陆莫拉菌和痤疮丙酸杆菌,分别获得奥斯陆莫拉菌的水平(M)和痤疮丙酸杆菌的水平(C);(1) Provide a sample derived from the skin of the subject to be tested, and detect the level of each marker in the sample marker combination, where the combination includes the following markers: Moraxella oslo and Propionibacterium acnes, obtained respectively The level of Lageria (M) and the level of P. acnes (C);
    (2)基于奥斯陆莫拉菌的水平(如含量)(M),或将所述样品中的奥斯陆莫拉菌的水平(M)与痤疮丙酸杆菌的水平(C)进行比较,从而对待测对象的皮肤进行分型、和/或判断皮肤状态。(2) based on the level (such as content) (M) of Moraxella oslo, or by comparing the level (M) of Moraxella oslo with the level (C) of P. acnes in the sample, so as to be tested. The subject's skin is typed, and/or the skin condition is judged.
  6. 如权利要求5所述的方法,其特征在于,步骤(2)中,根据奥斯陆莫拉菌的水平(M)与痤疮丙酸杆菌的水平(C)的相对值(比如M/C)对皮肤进行分型,或判断样本的皮肤状态。The method according to claim 5, wherein in step (2), according to the relative value (such as M/C) of the level (M) of Moraxella oslo and the level (C) of Propionibacterium acnes (such as M/C) Type, or judge the skin condition of the sample.
  7. 一种皮肤分型和/或检测皮肤状态的试剂组合,其特征在于,所述试剂组合包括用于检测权利要求3所述的组合中各个标志物的试剂。A reagent combination for skin typing and/or skin condition detection, characterized in that, the reagent combination includes a reagent for detecting each marker in the combination according to claim 3.
  8. 一种试剂盒,其特征在于,所述的试剂盒包括权利要求7所述的试剂组合。A kit, characterized in that the kit comprises the reagent combination of claim 7 .
  9. 一种对待测对象的皮肤进行分型和/或判断待测对象的皮肤状态的系统,其特征在于,所述系统包括:A system for classifying the skin of an object to be tested and/or judging the state of the skin of the object to be tested, wherein the system comprises:
    (a)特征接收模块,所述特征接收模块用于接收皮肤样本特征数据;所述的特征数据包括:皮肤样本中的奥斯陆莫拉菌(M)和痤疮丙酸杆菌(C)各自的定量信息;(a) a feature receiving module, the feature receiving module is used for receiving skin sample feature data; the feature data includes: the quantitative information of each of Moraxella oslo (M) and P. acnes (C) in the skin sample ;
    (b)计算处理模块,用于计算来自所述特征接收模块的特征数据,从而获得各个特征各自的比例或各个特征之间的比例关系;并且基于所获得的各自的比例或各个特征之间的比例关系,与皮肤分型或特征表征的标准值进行比较,从而得出皮肤分型和/或皮肤状态的判断结果;和(b) a calculation processing module for calculating the feature data from the feature receiving module, so as to obtain the respective proportions of the respective features or the proportional relationship between the respective features; and based on the obtained respective proportions or the relationship between the respective features A proportional relationship, compared with a standard value for skin type or characterization, resulting in a judgment of skin type and/or skin condition; and
    (c)结果输出模块,所述输出模块用于接收并输出判断结果。(c) a result output module, the output module is used for receiving and outputting the judgment result.
  10. 如权利要求9所述的系统,其特征在于,所述定量信息的获取方法包括:测序、PCR、蛋白定量检测。The system of claim 9, wherein the method for obtaining the quantitative information comprises: sequencing, PCR, and quantitative protein detection.
  11. 一种筛选改善皮肤状态物质或成分的方法,其特征在于,包括:A method for screening skin condition-improving substances or ingredients, comprising:
    (a)提供一筛选菌,所述筛选菌是奥斯陆莫拉菌(M)、痤疮丙酸杆菌(C)、或包含奥斯陆莫拉菌和/或痤疮丙酸杆菌的筛选菌;(a) providing a screening bacteria, the screening bacteria is Moraxella oslo (M), P. acnes (C), or screening bacteria comprising Moraxella oslo and/or P. acnes;
    (b)将待筛选的物质或成分与所述筛选菌进行共培养,并检测奥斯陆莫拉菌或痤疮丙酸杆菌各自的水平;或奥斯陆莫拉菌与痤疮丙酸杆菌之间的相对水平(M/C);(b) co-culturing the substance or component to be screened with the screening bacteria, and detecting the respective levels of Moraxella oslo or P. acnes; or the relative level between Moraxella oslo and P. acnes ( M/C);
    (c)根据(b)培养后奥斯陆莫拉菌或痤疮丙酸杆菌各自的水平;或奥斯陆莫拉菌与痤疮丙酸杆菌之间的相对水平(M/C),从而判断所述待筛选的物质或成分为改善皮肤状态物质或成分。(c) according to (b) the respective levels of Moraxella oslo or P. acnes after culture; or the relative level (M/C) between Moraxella oslo and P. acnes, thereby judging the to-be-screened The substance or ingredient is a skin condition-improving substance or ingredient.
  12. 如权利要求11所述的方法,其特征在于,步骤(c)中奥斯陆莫拉菌的水平提高,或奥斯陆莫拉菌与痤疮丙酸杆菌之间的相对水平(M/C)提高,或痤疮丙酸杆菌的水平降低,或痤疮丙酸杆菌与奥斯陆莫拉菌之间的相对水平(C/M)降低时,所述待筛选的物质或成分为用于治疗痤疮的物质;和/或步骤(c)中奥斯陆莫拉菌的水平下降,或奥斯陆莫拉菌与痤疮丙酸杆菌之间的相对水平(M/C)下降,或痤疮丙酸杆菌的水平提高,或痤疮丙酸杆菌与奥斯陆莫拉菌之间的相对水平(C/M)提高,所述待筛选的物质或成分为皮肤抗衰老物质。The method of claim 11, wherein in step (c), the level of Moraxella oslo is increased, or the relative level (M/C) between Moraxella oslo and P. acnes is increased, or acne When the level of Propionibacterium is decreased, or the relative level (C/M) between Propionibacterium acnes and Moraxella oslo is decreased, the substance or ingredient to be screened is a substance for treating acne; and/or step (c) decreased levels of Moraxella oslo, or decreased relative levels (M/C) between Moraxella oslo and P. acnes, or increased levels of P. acnes, or increased levels of P. acnes and P. acnes The relative level (C/M) of Moraxella was increased, and the substance or ingredient to be screened was a skin anti-aging substance.
  13. 一种权利要求3所述的标志物组合或权利要求7所述的试剂组合的用途,其特征在于,(a)用于制备一试剂盒,所述试剂盒用于皮肤分型,和/或判断或表征皮肤状态;和/或(b)用于筛选改善皮肤状态的物质或成分。A use of the combination of markers of claim 3 or the combination of reagents of claim 7, wherein (a) is used to prepare a kit for skin typing, and/or Assessing or characterizing skin condition; and/or (b) screening for substances or ingredients that improve skin condition.
PCT/CN2021/135870 2020-12-08 2021-12-06 Marker combination for skin typing and use thereof WO2022121864A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020237023407A KR20230118928A (en) 2020-12-08 2021-12-06 Marker combination for skin typing and its application
JP2023535014A JP2023552837A (en) 2020-12-08 2021-12-06 Marker combinations and their use for skin classification

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202011444009 2020-12-08
CN202011444009.3 2020-12-08

Publications (1)

Publication Number Publication Date
WO2022121864A1 true WO2022121864A1 (en) 2022-06-16

Family

ID=81898667

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/135870 WO2022121864A1 (en) 2020-12-08 2021-12-06 Marker combination for skin typing and use thereof

Country Status (4)

Country Link
JP (1) JP2023552837A (en)
KR (1) KR20230118928A (en)
CN (1) CN114622024A (en)
WO (1) WO2022121864A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102465182A (en) * 2010-10-29 2012-05-23 株式会社爱茉莉太平洋 Detection kit for skin-active ingredients and method for detecting skin-active ingredients by using the same
CN103898006A (en) * 2014-01-28 2014-07-02 重庆市畜牧科学院 Goat source moraxella osloensis and specific segment for molecular identification of goat source moraxella osloensis as well as application of specific segment
CN108690881A (en) * 2017-03-30 2018-10-23 欧蒙医学诊断技术有限公司 Measuring method for diagnosing dermatophytosis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102465182A (en) * 2010-10-29 2012-05-23 株式会社爱茉莉太平洋 Detection kit for skin-active ingredients and method for detecting skin-active ingredients by using the same
CN103898006A (en) * 2014-01-28 2014-07-02 重庆市畜牧科学院 Goat source moraxella osloensis and specific segment for molecular identification of goat source moraxella osloensis as well as application of specific segment
CN108690881A (en) * 2017-03-30 2018-10-23 欧蒙医学诊断技术有限公司 Measuring method for diagnosing dermatophytosis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ALKHATIB NIDAL J., YOUNIS MANAF H., ALOBAIDI AHMAD S., SHAATH NEBAL M.: "An unusual osteomyelitis caused by Moraxella osloensis: A case report", INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, ELSEVIER, AMSTERDAM, NL, vol. 41, 1 January 2017 (2017-01-01), AMSTERDAM, NL, pages 146 - 149, XP055941183, ISSN: 2210-2612, DOI: 10.1016/j.ijscr.2017.10.022 *
LIM JAE YUN, HWANG INGYU, GANZORIG MUNKHTSATSRAL, HUANG SHIR-LY, CHO GYU-SUNG, FRANZ CHARLES M. A. P., LEE KYOUNG: "Complete Genome Sequences of Three Moraxella osloensis Strains Isolated from Human Skin", GENOME ANNOUNCEMENTS, vol. 6, no. 3, 18 January 2018 (2018-01-18), XP055941180, DOI: 10.1128/genomeA.01509-17 *

Also Published As

Publication number Publication date
CN114622024A (en) 2022-06-14
KR20230118928A (en) 2023-08-14
JP2023552837A (en) 2023-12-19

Similar Documents

Publication Publication Date Title
Boxberger et al. Challenges in exploring and manipulating the human skin microbiome
Saxena et al. Comparison of healthy and dandruff scalp microbiome reveals the role of commensals in scalp health
Hyde et al. Metagenomic analysis of nitrate-reducing bacteria in the oral cavity: implications for nitric oxide homeostasis
Howard et al. Aging-associated changes in the adult human skin microbiome and the host factors that affect skin microbiome composition
Trappetti et al. The impact of the competence quorum sensing system on Streptococcus pneumoniae biofilms varies depending on the experimental model
Khayyira et al. Simultaneous profiling and cultivation of the skin microbiome of healthy young adult skin for the development of therapeutic agents
CN109589275A (en) Ectoin is maintaining the purposes in skin microecological balance
CN114717128B (en) Lactobacillus reuteri with effects of improving aging skin and enhancing hair health and application thereof
CN111944713B (en) Pediococcus acidilactici with excellent alcohol stress resistance and application thereof
CN114574393A (en) Lactobacillus delbrueckii SEUNEU-110 and application thereof in skin
Marques et al. Phenotypic characterization of mastitic Prototheca spp. isolates
WO2022121864A1 (en) Marker combination for skin typing and use thereof
Patil et al. Isolation and characterisation of Lactobacillus species from sheep milk
Li et al. Comparative genomics of in vitro and in vivo evolution of probiotics reveals energy restriction not the main evolution driving force in short term
KR20230104670A (en) Novel compositions for the treatment of skin conditions
AL-ZAIDI et al. Molecular determination of the microbial diversity associated with vaginitis and testing their sensitivity to selected antimicrobials
Xia et al. Integration of skin phenome and microbiome reveals the key role of bacteria in human skin aging
Hussain et al. MALDI-TOF vs. VITEK 2 for identification of Aggregatibacter actinomycetemcomitans chest wall abscess
Cui et al. Metagenomic insights into the effects of cosmetics containing complex polysaccharides on the composition of skin microbiota in females
Li et al. The prebiotic effect of triple biotic technology on skin health
Diouf et al. Description of Streptococcus thalassemiae sp. nov., a Bacterium Isolated from Human Blood
Wilson The human microbiota: an historical perspective
Ze’evi Ma’or et al. Topical Application of Synbiotic Bacillus Preparations Positively Affects Skin (Micro) Biology
CN110616163B (en) Enterococcus faecalis capable of reducing concentration of trimethylamine and preparation method and application thereof
CN117551590B (en) Bifidobacterium longum subspecies infantis, microbial agent and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21902569

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2023535014

Country of ref document: JP

ENP Entry into the national phase

Ref document number: 20237023407

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 11202305203Y

Country of ref document: SG

122 Ep: pct application non-entry in european phase

Ref document number: 21902569

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 16/11/2023)